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Opioids and opioid-conditioned stimuli (CS) negatively alter host immunity, impairing 
the response to pathogens during opioid use and following drug cessation. Using male rats, our 
laboratory has determined that heroin or heroin-CS exposure preceding an endotoxin challenge 
markedly suppresses induction of peripheral pro-inflammatory biomarkers. It is unknown 
whether these heroin-induced and -conditioned effects extend to the female immune response. 
Aim 1 tested the effects of heroin and heroin-CS on endotoxin-induced peripheral nitric oxide 
(NO), a critical pro-inflammatory mediator, in female rats. Findings demonstrate both heroin 
administration alone and exposure to heroin-CS suppressed endotoxin-induced indices of NO 
production in spleen and plasma across sex. Results are the first to indicate that female rats 
express heroin-induced and -conditioned immunomodulation to endotoxin challenge. 
Our laboratory discovered that the dorsal hippocampus (DH) is responsible for context- 
heroin conditioned suppression of peripheral NO production. Within the DH, astrocyte activity 
and expression of interleukin-1β (IL-1β) are required during CS exposure for the expression of 
heroin-conditioned immunomodulation. Aim 2 tested involvement of the active IL-1 receptor in 
the expression of heroin-conditioned immune impairment. Further, we began to identify the 
relationship between IL-1 and astrocytes in our model. We investigated the consequence of 
heroin conditioning and CS exposure on expression of DH IL-1β and IL-1R1, and specifically, 
how these proteins changed in astrocytes. Results demonstrate that IL-1R1-mediated signaling is 
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required during CS exposure for the expression of conditioned immunomodulation and identified 
time-dependent, subregion-specific effects of CS exposure on astroglial IL-1β and IL-1R1. Aim 
3 employed a viral strategy to fluorescently tag hippocampal astrocytes to visualize these cells in 
rich detail. The structural properties and synaptic interactions of individual DH astrocytes were 
analyzed following a history of heroin conditioning and CS exposure. Results indicate 
heterogeneous alterations throughout the DH in astrocyte morphology and synaptic interactions 
as a result of exposure to the heroin-conditioned context. 
This dissertation provides insight into health detriments stemming from context-heroin 
associations and demonstrates both heroin and heroin-conditioned contextual stimuli negatively 
modulate the immune response across sex. The expression of heroin-conditioned 
immunomodulation is driven by DH neuroimmune mechanisms, with CS exposure affecting 
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CHAPTER 1: GENERAL INTRODUCTION 
The current heroin epidemic is a devastating public health crisis that poses a significant 
economic burden (e.g. (Mark et al., 2001; Shipton, 2018; Shipton et al., 2018)). In 2015, the 
societal cost of heroin use disorders was close to $51.2 billion, with a substantial amount 
attributed to direct medical costs, including addiction treatment and combating infection 
associated with use (Jiang et al., 2017). As the current COVID-19 pandemic has significantly 
worsened the ongoing opioid crisis (Khatri and Perrone, 2020; Silva and Kelly, 2020), the 
economic toll is likely much higher today. The detrimental consequences of opioid use are 
exacerbated by conditioned responses that stem from the association between a drug-paired 
context and drug use. Drug-associated contexts serve an important role in maintaining addiction 
by increasing the likelihood of relapse [e.g. (Bossert et al., 2016; Childress et al., 1993; Childress 
et al., 1986; See, 2002)]. Additionally, these heroin-associated stimuli drive other conditioned 
responses, such as heroin-conditioned peripheral immune alterations (Lysle and Ijames, 2002). 
Heroin negatively alters host immunity and decreases pathogen resistance by dampening the 
induction of peripheral pro-inflammatory agents such as cytokines, circulating lymphocytes, and 
inducible nitric oxide (Govitrapong et al., 1998; McCarthy et al., 2001; Nair et al., 1986). 
Moreover, heroin-induced immunomodulation may be particularly harmful for users diagnosed 
with HIV, a disease occurring at a disproportionally high rate in this population (Todd et al., 
2007), as it could dampen the already impaired pro-inflammatory response to infection 
(Meijerink et al., 2015). 
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Our laboratory was the first to establish that heroin-induced immunomodulation can 
become conditioned to environmental contexts repeatedly paired with use (Lysle and Ijames, 
2002). We reliably demonstrate that exposure to heroin-paired stimuli alone is sufficient to elicit 
pronounced suppression of peripheral nitric oxide and cytokine production following endotoxin 
exposure [e.g. (Lysle and Ijames, 2002; Saurer et al., 2008; Szczytkowski and Lysle, 2008)]. Our 
laboratory has extensively characterized these effects using male rats and determined that it is a 
Pavlovian conditioned response. Further, both heroin-induced and -conditioned 
immunomodulation are mediated by the central nervous system (Fecho et al., 1996; Hutson et al., 
2014; Lebonville et al., 2016; Lebonville et al., 2020; Lysle et al., 1996; Paniccia et al., 2018; 
Saurer et al., 2009; Szczytkowski et al., 2011; Szczytkowski et al., 2013; Szczytkowski and 
Lysle, 2007; Szczytkowski and Lysle, 2008). Our results suggest that conditioning processes 
extend heroin’s deleterious health effects past drug cessation. Thus, investigations into heroin- 
induced and -conditioned peripheral immunomodulation could have clinical relevance, 
particularly for long-term heroin users and those in recovery. 
Repeated pairings between environmental stimuli and the subjective and physiological 
effects of heroin result in robust associative learning. The consequent stimulus control over 
physiology and behavior is integral to heroin addiction, and has detrimental health consequences 
that represent a growing public health concern. Heroin-associated contextual stimuli can act as 
conditioned stimuli (CS) that trigger Pavlovian conditioned responses, including conditioned place 
preference (CPP) (Tzschentke, 1998) and conditioned immunomodulation (Lysle and Ijames, 
2002). Additionally, drug-paired contextual stimuli can act as discriminative stimuli or occasion 
setters that signal drug availability and thus engender drug-seeking behavior in instrumental 
paradigms (Crombag et al., 2008; Fuchs et al., 2008). Regardless of the specific role of the 
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contextual stimulus, the hippocampus is essential for context-drug associative learning (Kutlu and 
Gould, 2016). In particular, the dorsal hippocampus (DH) plays a critical role in drug-induced CPP 
(Corrigall and Linseman, 1988; Meyers et al., 2003; Xia et al., 2017) as well as context-induced 
drug-seeking behaviors (Fuchs et al., 2005; Fuchs Rita et al., 2007; Ge et al., 2017; Xie et al., 
2010). 
Our laboratory has made tremendous progress in the study of context-heroin conditioned 
responses. We established that heroin-conditioned immunomodulation is a classically 
conditioned response that is mediated through distinct hippocampal processes (Lebonville et al., 
2020; Paniccia et al., 2018; Szczytkowski et al., 2013; Szczytkowski and Lysle, 2007). DH 
signaling is required for both the acquisition of the context-heroin association as well as the 
expression of the conditioned immune effect (Lebonville et al., 2016; Lebonville et al., 2020; 
Szczytkowski et al., 2013). Within the DH, we have determined that neuroimmune processes are 
key to the expression of heroin-conditioned suppression of peripheral nitric oxide production 
(Paniccia et al., 2018; Szczytkowski et al., 2013). Specifically, expression of the pro- 
inflammatory cytokine, interleukin-1β (IL-1β) (Szczytkowski et al., 2013), and stimulation of its 
active receptor, IL-1 receptor type 1 (IL-1R1) [see Chapter 3 and (Lebonville et al., 2016; 
Paniccia et al., 2018)], are critical for heroin-conditioned immunomodulation to occur. While 
multiple CNS cell types are able to produce and receive IL-1 signaling (Hanisch, 2002; 
Srinivasan et al., 2004), there is evidence suggesting that DH astroglia support hippocampal- 
dependent learning and memory through expression of both IL-1β (Jones et al., 2018a) and IL- 
1R1 (Ben Menachem-Zidon et al., 2011). To further investigate this cell type in our model, we 
employed chemogenetic tools to selectively target and manipulate DH astroglia in vivo. Our 
published work demonstrates that stimulation of astroglial Gi-coupled designer receptors 
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exclusively activated by designer drugs (DREADDs) during CS exposure disrupts heroin- 
conditioned immunomodulation (Paniccia et al., 2018). Thus, separately, intact DH IL-1 and 
astrocyte signaling are critical to the context-heroin association driving conditioned suppression 
of immune status. 
Hippocampal mechanisms are indeed critical for context-drug associative learning (Kutlu 
and Gould, 2016; Luo et al., 2011), and hippocampal astrocytes have emerged as key regulators 
of the neural environment. DH astroglia mediate learning and memory processes, including 
synaptic plasticity, in part through glial-derived cytokines (Ben Menachem-Zidon et al., 2011; 
Ota et al., 2013; Santello and Volterra, 2012). Their unique morphology allows them to directly 
contact and monitor thousands of synapses and respond to a large number of neurons (Agulhon 
et al., 2008; Arizono et al., 2020; Harada et al., 2015). Consequently, opioid-induced changes in 
astrocyte physiology may contribute to addictive behaviors and drive heroin reinstatement 
(Kruyer et al., 2020; Kruyer et al., 2019) and immune impairment. However, the impact of 
heroin conditioning and CS exposure on hippocampal astrocyte physiology is currently 
unknown. Moreover, there is no established relationship between DH astrocytes and IL-1 
signaling in heroin-conditioned immunomodulation. 
The goal of this dissertation was to investigate heroin-conditioned changes in astrocyte 
physiology and explore the astrocyte/IL-1 relationship as a mechanism underlying context-heroin 
conditioned suppression of immune status. As studies examining heroin-conditioned 
immunomodulation have historically been carried out using male rats, Chapter 2 aimed to 
explore heroin-induced and -conditioned suppression of peripheral immune status in females. 
Chapter 3 focused on the role of DH IL-1R1-mediated signaling in the expression of heroin- 
conditioned immunomodulation and outcome of CS exposure on IL-1β and IL-1R1 mRNA and 
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protein expression. To begin investigations into the astrocyte/IL-1 relationship, Chapter 3 also 
examined astrocyte-specific changes in DH IL-1β and IL-1R1, two critical components of IL-1 
signaling. Subsequently, Chapter 4 assessed heroin-conditioned and CS-induced changes on 
astrocyte physiology in three DH subregions, the dentate gyrus, CA3, and CA1. The 
hippocampus is a heterogeneous structure with distinct anatomical connections (Fanselow and 
Dong, 2010), and these three subregions are integral for information flow. The dentate gyrus, 
CA3, and CA1 regions compose the “trisynaptic loop” in which information comes into the 
dentate gyrus through the perforant path, dentate gyrus neurons synapse with CA3 neurons via 
the mossy fiber pathway, and CA3 projects to CA1 through the Schaffer Collateral pathway 
(Knierim, 2015). CA1 is one of the main output regions of the hippocampus, and we recently 
established the importance of DH excitatory efferent neurons in our heroin-conditioned immune 
effect (Lebonville et al., 2020). Chapter 4 uses high resolution microscopy and advanced cellular 
analysis coupled with fluorescent immunohistochemistry (IHC) to quantify changes in DH 
astrocyte surface area, volume, and colocalization with postsynaptic density 95 (PSD-95), a 
postsynaptic scaffolding protein expressed in glutamatergic neurons. Astrocyte colocalization 
with PSD-95 is used as a proxy for astrocyte-neuron interactions. Collectively, this dissertation 
provides insight into the complex neuroimmune mechanisms regulating context-heroin 








CHAPTER 2: FEMALE RATS EXPRESS HEROIN-INDUCED AND -CONDITIONED 





Chapter 2 tested whether female Lewis rats exhibit heroin-induced and – 
conditioned peripheral immunomodulation. Traditionally, animal models investigating opioid- 
related health consequences have focused on males. However, females experience distinct 
behavioral patterns and biological responses associated with opioid use (Iversen et al., 2010; 
Jamison et al., 2010) that might make them more vulnerable to opioid-related effects, and in 
particular, heroin-induced and -conditioned immunomodulation. For instance, women are more 
likely to be prescribed opioid analgesics and are at a greater risk of misusing prescription opioids 
(Koons et al., 2018), which is often a precursor for heroin use (Lankenau et al., 2012). Consistent 
with this, heroin use has disproportionally increased among women in recent years, with the 
incidence of heroin use doubling among women in the United States (Jones et al., 2015a). 
Further, heroin-paired cues appear to elicit stronger physiological and motivated responses in 
women than in men (Yu et al., 2007). Sex differences in opioid use/taking behavior exist in the 
pre-clinical literature as well. Female rats have been shown to acquire heroin self-administration 
faster than males (Lynch and Carroll, 1999), suggesting a distinct sex-specific behavioral pattern 
in drug-taking behavior. 
 
1This chapter previously appeared as an article in the journal Brain, Behavior, and Immunity. The original citation is 
as follows: Paniccia, .J.E., Weckstein, .T.N., Lebonville, .C.L., & Lysle, D.T. (2021). Female rats express heroin- 
induced and -conditioned suppression of peripheral nitric oxide production in response to endotoxin challenge. 
Brain, behavior, and immunity, 91:315-323. doi: 10.1016/j.bbi.2020.10.009. 
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Although the literature indicates females display increased heroin taking behavior and 
reactivity to heroin-related cues, there are existing discrepancies regarding sex differences in 
some of these same opioid-induced responses in both clinical populations and pre-clinical 
models of heroin use disorders (Lynch et al., 2002). For example, Kennedy and colleagues found 
no sex differences in amount of heroin used or treatment retention, and that women were less 
likely to crave drug after seeing others use heroin (Kennedy et al., 2013). Similarly, some pre- 
clinical results demonstrate no sex-related effects in heroin self-administration, total heroin 
intake, breakpoint, or heroin craving following abstinence in male and female rats (Lynch et al., 
2002; Venniro et al., 2017). It is apparent that there are conflicting reports on whether sex 
differences exist in heroin-induced responses, such as self-administration and craving caused by 
heroin-paired cues. Given this, it is important to test potential sex differences continually in 
heroin-induced behaviors and responses and gain insight into how the response in question is 
affected based on biological sex. 
Importantly for the current study, sex differences exist in the immune response (Klein, 
2004; Schwarz and Bilbo, 2012) and in opioid-immune interactions (Doyle and Murphy, 2017). 
There is evidence to suggest females have a more robust innate immune response than males and 
tend to show higher levels of cytokine production following exposure to an immune challenge 
with lipopolysaccharide [LPS; (Engler et al., 2016)]. LPS stimulation of innate immune toll-like 
receptor 4 (TLR4) signaling may contribute to this exacerbated cytokine response in females 
(Kovats, 2015). Interestingly, opioids also bind to TLR4, and TLR4 stimulation modulates 
opioid pharmacodynamics (Shah et al., 2016). Opioids have alternatively been shown to 
negatively modulate activity downstream of TLR4 stimulation, disrupting pro-inflammatory 
responses, including production of cytokines and NO (Eisenstein, 2019). Sex differences in 
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innate immunity, combined with differences in direct opioid-immune interaction may, in part, 
account for sex-based differences in the behavioral effects of opioids (Doyle and Murphy, 2017; 
Doyle and Murphy, 2018), but testing opioid-related health consequences mostly in males has 
left a disparity in understanding how opioids affect female health. Presently, it is unknown if 
heroin’s deleterious impact on immune function extends to females, and if present, whether this 
heroin-induced immunomodulation can become conditioned to environmental stimuli. 
The current set of experiments investigated whether heroin suppresses the peripheral 
immune response in female rats as compared to males (Experiment 1) and if female rats express 
context-heroin conditioned immunomodulation (Experiment 2). Our laboratory has a long 
history of examining the effect of heroin and heroin-paired cues on the immune response in male 
rats [e.g. (Fecho and Lysle, 2000; Lanier et al., 2002; Lysle and How, 2000; Lysle and Ijames, 
2002)], and is well-positioned to investigate heroin-induced and -conditioned alterations in 
peripheral nitric oxide (NO) production in females. NO is a critical component of host immunity 
(Breitbach et al., 2006; Hoffmann et al., 2006; Oates and Gilkeson, 2006). For instance, NO is an 
essential modulator of T-cell activation and proliferation, B-cell maturation and proliferation, 
immunoglobulin production, and the synthesis of numerous cytokines (Bogdan et al., 2000). To 
assess the impact of heroin and heroin-conditioned stimuli (CS) on peripheral NO, we analyze 
the pro-inflammatory indices of NO production: inducible nitric oxide synthase (iNOS; the 
enzyme that is responsible for NO production) and plasma nitrate/nitrite concentration (the 
degradation product of NO). These indices of NO production are potently upregulated by an 
immune challenge like LPS (Bogdan, 2001) and changes in peripheral iNOS expression and 
nitrate/nitrite concentration are some of the most reliable and sensitive indices of alterations of 
immune status in vivo. 
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The current study employed LPS to mimic bacterial infection and trigger pro- 
inflammatory responses that permit observation of heroin-induced and -conditioned changes in 
NO production. We have reliably used LPS in male rats to stimulate the immune system and 
examine how heroin and heroin-CS alter peripheral indices of NO production in vivo [e.g. 
(Hutson et al., 2014; Lebonville et al., 2016; Lebonville et al., 2020; Paniccia et al., 2018; 
Szczytkowski et al., 2013)]. LPS is a component of the cell wall of Gram-negative bacteria, and 
it is the most widely recognized agent that effectively and reliably stimulates immune responses 
(Liu et al., 1993; Liu et al., 1997; Tracey et al., 1995). Thus, we administer LPS following heroin 
and heroin-CS exposure to examine alterations in the pro-inflammatory biomarkers of NO 
production, specifically within the spleen and blood plasma of female rats. Naturally cycling 
female rats were used in both experiments, and estrous phase was examined at the time of tissue 
collection for potential indication of cycle effects on heroin-induced or -conditioned NO 
suppression. Collectively, these studies provide insight into the negative health consequences of 
heroin use in females and examine if females, like males, are susceptible to heroin-conditioned 
immunomodulation that would extend these deleterious effects past drug cessation. 




Adult male and female Lewis rats (N = 68; 18 males, 50 females) were purchased from Charles 
River Laboratories (Kingston, NY, USA). Historically, Lewis rats have been the preferred strain 
for investigating the inflammatory response of nitric oxide (Misiewicz et al., 1996; Salvemini et 
al., 1995), as well as opioid-induced effects [e.g., (Ambrosio et al., 1995; Guitart et al., 1992; 
Guitart et al., 1993; Suzuki et al., 1988)], in a rat model. Rats were individually housed on a 12- 
hour reverse light-dark cycle, received ad libitum home cage access to food and water, and were 
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handled regularly throughout experimentation. All procedures took place during the dark phase 
of the light cycle and were conducted in compliance with regulations set forth by the National 
Research Council’s Guide for the Care and Use of Laboratory Animals and the University of 
North Carolina at Chapel Hill Institutional Animal Care and Use Committee. 
Drug Administration 
 
Heroin (diacetylmorphine, National Institute on Drug Abuse Drug Supply Program, Bethesda, 
MD, and USA) was dissolved in 0.9% sterile saline vehicle and stored at 4°C until use at room 
temperature. Heroin was administered subcutaneously (s.c.) at a dose of either 1 or 3 mg/kg in 
Experiment 1 and at a dose of 1 mg/kg in Experiment 2. Lipopolysaccharide (LPS; derived from 
E. coli, serotype O55:B5, Millipore-Sigma, Burlington, MA, USA) was dissolved in 0.9% sterile, 
pyrogen-free saline to a final dose of 1 mg/kg and was administered s.c. in all experiments. This 
LPS dose reliably produces sickness behavior, induces production of peripheral NO, and can be 
used to examine heroin-induced and -conditioned effects on NO production (Lysle and How, 
2000; Lysle and Ijames, 2002). 
Heroin-induced and -conditioned Immunomodulation and Testing 
 
Experiment 1: Heroin-induced Peripheral Immunomodulation 
 
Male and female rats (N = 18/sex) were randomly assigned to groups in a 2 (sex) x 3 (heroin 
dose) between-subjects design. Animals received one of three drug doses: 0 (0.9% sterile saline 
vehicle), 1, or 3 mg/kg, and were left undisturbed in home cage for 1 hour. Subsequently, rats 
received an LPS injection to stimulate an immune response and remained in home cage until 
tissue collection 6 hours later. We have reliably observed heroin-related alteration of LPS- 
induced peripheral NO production through measurement of splenic iNOS expression and plasma 
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degradation products at this time point, which is near the peak of LPS-induced NO production 
(Lysle and How, 1999, 2000; Lysle and Ijames, 2002). 
Experiment 2: Heroin-conditioned Peripheral Immunomodulation 
 
Naturally cycling female rats (N = 32) were randomly assigned to groups in a 2 (drug condition) 
x 2 (CS exposure) between-subjects design. The heroin conditioning paradigm employed herein 
has been previously described [see (Paniccia et al., 2018)]. In short, animals were subject to five, 
1-hour conditioning sessions in which heroin (or saline vehicle as a control) was paired with a 
standard conditioning chamber (BRS/LVE, Laurel, MD, USA; H 26.7 cm × D 24.1 cm × W 30.5 
cm). The chamber served as the conditioned stimulus (CS) and was located in a room adjacent to 
the vivarium. Each chamber contained metal bar flooring and cedar bedding. Conditioning 
chambers were located within sound- and light-attenuating chambers (H 36.8 cm x D 34.3 cm x 
W 50.8 cm) with a fan used to mask background noise. This setup created an environmental CS 
with olfactory, tactile, auditory, and visual cues distinct from home cage stimuli. Conditioning 
sessions were separated by 48 hours. Following the conditioning procedure, animals remained 
undisturbed in home cage for six days until the conditioning test. On test day, rats were either re- 
exposed to the CS for 1 hour or remained in home cage as controls. Immediately following CS 
exposure or home cage stay, animals were administered LPS and remained in home cage for 6 
hours until tissue collection. Saline-conditioned animals controlled for ancillary effects from 
exposure to heroin, the conditioning chamber, and the injection experience. 
Tissue Collection 
 
Animals were sacrificed via rapid cervical dislocation without anesthesia. Spleen tissue and 
blood plasma were collected for later analysis of iNOS expression and nitrate/nitrite 
concentration, respectively. Spleen tissue for RNA and protein analyses was divided into ~100 
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mg samples and were stored at -80°C in either RNAlater (Ambion, ThermoFisher Scientific, 
Waltham, MA, USA) or cOmplete protease inhibitor cocktail (Roche, Millipore-Sigma) in 1X 
phosphate buffered saline until assay. 
Vaginal Lavage and Histology 
 
Vaginal lavages were taken post mortem to assess estrous stage on test day. Samples were 
smeared onto SuperFrost Plus slides (ThermoFisher Scientific), allowed to dry, and stained using 
a Wright Giemsa Stain, modified (Sigma-Aldrich) method. Vaginal cell distribution was 
examined using a Leica DM 6000B microscope (Leica Microsystems, Buffalo Grove, IL, USA) 
and estrous phase (diestrus, proestrus, estrus, or metestrus) was determined according to methods 
described by Cora and colleagues (Cora et al., 2015). 
RT-qPCR for Splenic iNOS mRNA Expression 
 
RNA Extraction and cDNA Synthesis 
 
RNA was extracted from spleen tissue to measure iNOS mRNA expression. Tissue was added to 
1 mL of cold TriReagent (Molecular Research Center, Cincinnati, OH, USA) and homogenized 
using a bead homogenizer (Precellys Instruments, Montigny-le-Bretonneux, France). Spleen 
homogenates were briefly centrifuged to remove debris and transferred to a second tube. Next, 
BCP (1-Bromo-3-Chloropropane; Molecular Research Center, Inc, Cincinnati, OH, USA) was 
added to the homogenate and samples were thoroughly mixed, incubated at room temperature for 
7 minutes, and centrifuged at 4° C for phase separation. The aqueous layer was mixed with 
isopropanol and incubated at room temperature for 7 min. Following this, samples were 
centrifuged at 4° C to collect the RNA pellet. RNA pellets were washed three times in 75% 
ethanol and allowed to air dry to remove residual ethanol. Purified RNA was reconstituted in 
warm, PCR-grade water. RNA concentration and purity were assessed via spectrophotometer 
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(Epoch™, BioTek Instruments Inc., Winooski, VT, USA) using the Take3 Application and Gen5 
Software for Nucleic Acid Quantification (BioTek Instruments Inc.). 
Sample RNA concentration was equalized to 1 μg in PCR-grade water for the cDNA 
reaction. cDNA was synthesized using the Advantage for RT-PCR Kit and Oligo(DT) primers 
(ClonTech, Takara, Mountain View, CA, USA) according to manufacturer’s protocol on a Veriti 
96 Well Fast Thermal Cycler (Applied Biosystems, ThermoFisher Scientific). Samples were 
diluted 1:5 in PCR-grade water for qPCR. 
RT-qPCR 
 
Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) was 
performed using the TaqMan™ Fast Advanced Master Mix Kit (Applied Biosystems, 
ThermoFisher Scientific), following the manufacturer’s instructions, to quantify splenic iNOS 
mRNA expression. Sample reactions were carried out in triplicate on a 384-well plate, with 
individual reactions containing 1.5 μL of cDNA. Predesigned fluorescein (FAM) assays were 
used to quantify expression of iNOS (NOS2, Assay ID: Rn00561646_m1, ThermoFisher 
Scientific) and reference gene 60S ribosomal protein L13a (Rpl13a, reference gene, Assay ID: 
Rn01475911_g1; ThermoFisher Scientific). No template control wells were run to ensure 
reaction purity. RT-qPCR was run on QuantStudioTM 6 Flex RealTime PCR System (Applied 
Biosystems, ThermoFisher Scientific) using the QuantStudioTM RealTime PCR Software with a 
PCR Run Method as follows: 2 min at 50°C for PCR product contamination degradation; 20 sec 
hold at 95°C for polymerase activation; 45 PCR cycles (1 sec at 95° C then 20 sec at 60° C) with 
data collection at the end of each cycle. The comparative delta delta CT (ΔΔCT) method was 
used for data analysis (Schmittgen and Livak, 2008). iNOS CT values were first normalized to 
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the reference gene (L13a) and then to the mean ∆CT of the entire data set. Linearly transformed 
values were used to display the data graphically. 
ELISA for Splenic iNOS Protein 
 
Protein was extracted from spleen tissue using bead homogenization and freeze-thaw lysis. A 
Bradford Assay was used to quantify total protein concentration for each sample. Briefly, 10 μL 
of diluted (1:200) sample, in duplicate, was incubated with 200 μL of diluted (1:4) and filtered 
Bio-Rad Protein Assay Dye Reagent (BioRad Laboratories, Hercules, CA, USA) for 10 min. 
Absorbance was measured via spectrophotometer (Epoch™, BioTek Instruments Inc.) at 595 
nm, averaged across sample duplicates, and compared to a concurrently run BSA standard curve 
to determine concentration (μg/μL). To measure splenic iNOS protein, samples were run in 
duplicate in a rat iNOS sandwich ELISA (Cat #: abx256135, Abbexa Ltd., Cambridge, UK) 
according to the manufacturer’s protocol. Input protein was equalized across all samples to 15 
μg, and pg quantity of iNOS protein per total protein was calculated based on a concurrently run 
standard curve. The sample duplicate mean iNOS protein quantity was used in data analysis. 
Griess Reagent Assay for Plasma Nitrate/Nitrite Concentration 
 
The degradation products of NO, nitrate and nitrite, were measured in blood plasma using the 
Griess reagent assay as previously described (Szczytkowski and Lysle, 2007). Briefly, samples 
were assayed in triplicate, and diluted plasma was incubated with nitrate reductase (1.0 U/mL), 
0.31 M phosphate buffer (pH = 7.5), 0.86 mM NADPH (Sigma-Aldrich Inc., Milwaukee, WI, 
USA), and 0.11 mM flavin adenine dinucleotide at room temperature in the dark for 90 minutes. 
Subsequently, Griess reagent [1:1 (vol:vol) solution 1% sulfanilamide in 5% phosphoric acid and 
0.1% N-(1-napthyl)ethylenediamine dihydrochloride in distilled H2O] was added to the samples 
and incubated for 10 minutes at room temperature. Absorbance was read at 550 nm using a 
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spectrophotometer (Epoch™, BioTek Instruments Inc), and concentration for each sample was 
determined based on a concurrently run standard curve. Mean concentration of sample triplicate 
was used in analysis. 
Statistical Analysis 
 
SPSS Statistics (IBM, Armonk, NY) was used to analyze data from each experiment. Results 
were analyzed using between-subjects analysis of variance (ANOVA). Statistically significant 
outliers were detected using Grubb’s test and were removed from data analysis. For all tests, 
alpha was set at p = .05. Tukey’s Honestly Significant Difference (HSD) post-hoc comparison 
was used to probe significant interactions and ancillary effects. 
Results 
 
Experiment 1: Heroin-induced Suppression of Peripheral NO Production Occurs in Both 
Sexes 
 
Experiment 1 investigated whether female rats exhibit comparable heroin-induced 
immunomodulation as male counterparts (see Fig. 1A for experimental timeline). Heroin 
administration significantly suppressed LPS-induced pro-inflammatory indices of NO production 
(Fig. 1B-D). Final group sizes were n = 5-6 after accounting for statistical outliers: four animals 
were removed from mRNA and one from protein analyses. 
A 2 x 3 ANOVA of splenic L13a mRNA levels revealed a main effect of sex (F(1, 28) = 
4.521, p = .042), but no effect of drug treatment (F(2,28) = 0.197, p = .823) nor interaction of the 
two (F(2,28) = 0.385, p = .684). Post hoc analysis revealed there were no significant differences 
between male and females in the saline-treated group (p = .992), 1 mg/kg heroin group (p = 
.803), or 3 mg/kg group heroin (p = .437). Thus, L13a was used as a reference gene in analysis. 
For splenic iNOS mRNA, a 2 x 3 ANOVA of ∆∆CT values revealed a main effect of sex 
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(F(1,26) = 21.16, p < .001) and a main effect of drug treatment (F(2,26) = 24.293, p < .001) but 
no interaction between the two [F(2, 26) = 2.137, p = .138; Fig. 1B]. Tukey’s HSD post hoc 
comparisons revealed that heroin significantly suppressed LPS-induced splenic iNOS mRNA 
expression relative to saline-treated counterparts in males at doses of 3 mg/kg (p = .021), but not 
at 1 mg/kg (p = .101). In females, heroin significantly blunted LPS-induced iNOS mRNA levels 
at 1 mg/kg (p < .001) and 3 mg/kg (p = .001) as compared to saline-treated controls. There were 
no differences in iNOS mRNA levels between the 1-mg/kg and 3-mg/kg heroin-treated females 
(p = .957), indicating both heroin doses produced comparable suppression of iNOS mRNA 
expression. Additionally, post hoc analysis revealed no significant difference between the saline- 
treated male and female groups (p = .793), whereas within the 1 mg/kg heroin treatment females 
had significantly lower iNOS levels than their male counterparts (p = .003). At 3 mg/kg, iNOS 
mRNA expression did not differ across sex (p = .162). 
Heroin exposure significantly blunted LPS-induced splenic iNOS protein expression 
(Fig. 1C). A 2 x 3 ANOVA of splenic iNOS protein concentration revealed a main effect of drug 
treatment (F(2, 29) = 31.356, p < .001), but no main effect of sex (F(1, 29) = 0.967, p = .333) nor 
sex x drug interaction (F(2, 29) = 1.701, p = .20). Tukey’s HSD post hoc comparisons revealed 
that as compared to saline-treated controls, 1 mg/kg of heroin significantly blunted LPS-induced 
iNOS protein in both females (p < .001) and males (p = .024). Similarly, 3 mg/kg heroin 
suppressed iNOS protein expression across sex, in that both males (p = .005) and females (p < 
.001) had significantly lower levels of iNOS protein than their saline-treated counterparts. There 
were no significant sex differences within the saline-treated group (p = .364), 1-mg/kg heroin 
group (p = .998), or 3-mg/kg heroin group (p = .999), demonstrating comparable levels of 
heroin-induced immunomodulation in both sexes. Additionally, there was no difference in iNOS 
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protein expression between the 1- and 3-mg/kg heroin-treated females (p = .999), indicating 
comparable heroin-induced iNOS protein suppression for both heroin doses. 
Consistent with splenic iNOS measures, heroin administration significantly suppressed 
LPS-induced plasma nitrate/nitrate concentration (Fig. 1D). A 2 x 3 ANOVA of plasma 
nitrate/nitrite concentration revealed a main effect of drug treatment (F(2, 30) = 21.258, p < 
.001), but no main effect of sex (F(1, 30) = 0.01, p = .923) nor interaction between the two (F(2, 
30) = 0.515, p = .515). For males, post hoc analysis revealed that when heroin administration 
preceded LPS challenge, doses of 1- (p = .016) or 3-mg/kg (p = .002) suppressed nitrate/nitrite 
concentration relative to saline controls. Similarly, females that were administered heroin at 1- (p 
= .001) or 3-mg/kg (p = .011) had significantly lower plasma nitrate/nitrite concentration 
compared to saline-treated counterparts. There were no significant sex differences within the 
saline-treated group (p = .999), 1-mg/kg heroin group (p = .962), or 3-mg/kg heroin group (p = 
.962), demonstrating comparable levels of heroin-induced immunomodulation across sex. There 
was no difference in heroin-induced suppression of nitrate/nitrite concentration between females 
that were administered 1- or 3-mg/kg heroin (p = .958), suggesting that both doses produced 
suppression of this measure. 
Although naturally cycling females exhibited heroin-induced suppression of NO in 
peripheral tissue and plasma, estrous phase was determined for each sample and categorized into 
diestrus, proestrus, estrus, or metestrus. Statistical analysis did not reveal significant differences 
in female heroin-induced immunomodulation between the 1- and 3-mg/kg doses of heroin, and 
as such, the heroin groups were combined to assess NO measures across estrous cycle. Final 
analyses of splenic iNOS expression and plasma nitrate/nitrite concentration (n = 6 in the saline- 
treated group and n = 11-12 in the heroin groups) when split across cycle did not yield a large 
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enough sample size per stage to probe effects of all four estrous phases on measures of peripheral 
NO. Given that rat samples in diestrus and proestrus are characterized as “increasing/high 
estradiol” and those in estrus and metestrus are characterized as “low estradiol” (Miller and 
Takahashi, 2014; Santmyire et al., 2010), a 2 (low vs high estradiol phase) x 2 (saline vs heroin) 
ANOVA was used to examine estradiol effects on NO production. Final group sizes per estradiol 
group was n = 3 for saline-treated and n = 4-7 for heroin-treated females. Analysis of iNOS 
∆∆CT values revealed a significant main effect of heroin (F(1, 13) = 60.266, p < .001) but no 
main effect of estradiol phase (F(1, 13) = 1.135, p = .306) or heroin treatment x estradiol 
interaction (F(1, 13) = .088, p = .772) (Fig. 1E). For iNOS protein, a 2 x 2 ANOVA revealed a 
main effect of heroin (F(1, 14) = 40.112, p < .001), but no main effect of estradiol phase (F(1, 
14) = 2.549, p = .133) or drug x estradiol interaction (F(1, 14) = 2.33, p = .149) (Fig. 1F). 
Similarly, analysis of nitrate/nitrite concentration revealed a significant main effect of heroin 
(F(1, 14) = 20.746, p < .001), but no main effect of estradiol phase (F(1, 14) = 1.834, p = .197) 
or drug x estradiol interaction (F(1, 14) = 1.209, p = .29) (Fig. 1G). Thus, estradiol phase did not 
significantly alter heroin-induced immunomodulation, since heroin consistently blunted LPS- 
induced indices of NO production. 
Experiment 2: Female Rats Exhibit Heroin-conditioned Immunomodulation 
Experiment 2 examined whether females would express heroin-conditioned peripheral 
immunomodulation following re-exposure to a heroin-paired context (see Fig. 2A for 
experimental timeline). Following context-heroin conditioning with a 1 mg/kg dose of heroin, 
CS exposure significantly suppressed the LPS-induced peripheral pro-inflammatory indices of 
NO production (Fig. 2B-D). Final group sizes were n = 7-8 after accounting for statistical 
outliers: two animals were excluded from mRNA and one from nitrate/nitrite analyses. 
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A 2 x 2 ANOVA of splenic L13a mRNA levels revealed no main effect of drug treatment 
(F(1, 28) = .421, p = .522), CS exposure (F(1, 28) = .486, p = .492), or drug treatment x CS 
exposure interaction (F(1, 28) = 1.24, p = .275), validating L13a’s use as an appropriate 
reference gene. For splenic iNOS ∆∆CT values, a 2 x 2 ANOVA revealed a significant drug 
treatment x CS exposure interaction (F(1, 26) = 25.476, p < .001), as well as significant main 
effects of drug treatment (F(1, 26) = 14.989 , p = .001) and CS exposure (F(1, 26) = 31.441, p < 
.001) (Fig. 2B). Post hoc analysis revealed that heroin-conditioned, CS-exposed animals had 
significantly suppressed LPS-induced iNOS mRNA levels relative to heroin-conditioned home 
cage counterparts (p < .001), as well as to saline-conditioned home cage (p < .001) and CS- 
exposed (p < .001) controls. 
Similar to splenic iNOS mRNA expression, prior CS exposure significantly blunted LPS- 
induced splenic iNOS protein concentration in heroin conditioned animals (Fig. 2C). A 2 x 2 
ANOVA of splenic iNOS protein revealed a significant drug treatment x CS exposure interaction 
(F(1, 28) = 25.687, p < .001), as well as significant main effects of drug treatment (F(1, 28) = 
14.509, p = .001) and CS exposure (F(1, 28) = 22.842, p < .001). Post hoc analysis revealed that 
heroin-conditioned, CS-exposed animals had significantly suppressed splenic iNOS protein 
concentrations relative to heroin-conditioned home cage counterparts (p < .001), as well as to 
saline-conditioned home cage (p < 0.001) and CS-exposed (p < 0.001) controls. 
Consistent with splenic iNOS measures, CS exposure significantly suppressed LPS- 
induced plasma nitrate/nitrite concentration in heroin-conditioned animals (Fig. 2D). A 2 x 2 
ANOVA of plasma nitrate/nitrite concentration revealed a significant drug treatment x CS 
exposure interaction (F(1, 27) = 13.925, p = .001), as well as significant main effects of drug 
treatment (F(1, 27) = 14.754, p = .001) and CS exposure (F(1, 27) = 16.413, p < .001). Post hoc 
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analysis revealed that when CS exposure preceded the LPS challenge, heroin-conditioned 
animals had lower plasma nitrate/nitrite concentration relative to heroin-conditioned home cage 
counterparts (p < .001), saline-conditioned home cage controls (p < .001) and saline-conditioned, 
CS-exposed controls (p < .001). 
Although naturally cycling females expressed heroin-conditioned suppression of NO in 
peripheral tissue and plasma, estrous phase was determined for each sample and categorized into 
diestrus, proestrus, estrus, or metestrus. Final analyses of splenic iNOS expression and plasma 
nitrate/nitrite concentration in the heroin conditioned groups (n = 7-8) when split across stage did 
not yield a large enough sample size to probe effects of estrous on CS-induced suppression of 
peripheral NO production. As in Experiment 1, samples in diestrus and proestrus were 
characterized as “increasing/high estradiol,” while those in estrus and metestrus were 
characterized as “low estradiol” (Miller and Takahashi, 2014; Santmyire et al., 2010). Indices of 
NO production in heroin-conditioned animals were analyzed using a 2 (estradiol phase, low vs 
high) x 2 (CS exposure, home cage vs CS) ANOVA. After combining, final group sizes for 
heroin-conditioned females per estradiol group was n = 2-6 (home cage controls) and n = 3-5 
(CS exposed). Analysis of iNOS ∆∆CT values revealed a significant main effect of CS exposure 
(F(1, 11) = 51.195, p < .001), but no main effect of estradiol phase (F(1, 11) = .108, p = .748) or 
CS x estradiol interaction (F(1, 11) = .29, p = .601) (Fig. 2E). For iNOS protein, a 2 x 2 
ANOVA revealed a main effect of CS (F(1, 12) = 32.899, p < .001), but no main effect of 
estradiol phase (F(1, 12) = .657, p = .433) or CS exposure x estradiol interaction (F(1, 12) = 
.484, p = .50) (Fig. 2F). Similarly, a 2 x 2 ANOVA of nitrate/nitrite concentration revealed a 
significant main effect of CS (F(1, 11) = 45.242, p < .001), but no main effect of estradiol phase 
(F(1, 11) = .442, p = .52) or CS x estradiol interaction (F(1, 11) = .323, p = .581) (Fig. 2G). 
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Thus, estradiol phase did not significantly alter heroin-conditioned immunomodulation as CS 




The present experiments establish that heroin directly modulates peripheral NO in female 
rats and that this effect can become conditioned to environmental stimuli previously paired with 
heroin administration. At two doses (1 and 3 mg/kg), heroin suppressed LPS-induced indices of 
peripheral NO production in both sexes, demonstrating for the first time that heroin-induced 
immunomodulation occurs in female rats to a comparable magnitude as in males. Further, both 
doses of heroin dampened multiple indices of LPS-induced NO production to the same degree in 
females and males, indicating that 1 mg/kg is sufficient to elicit heroin-induced 
immunomodulation in both sexes. Using the same context-heroin conditioning parameters we 
have reliably and reproducibly employed with males, the current study demonstrates that 
exposure to heroin-conditioned stimuli (CS) alone elicits heroin-conditioned suppression of LPS- 
induced peripheral NO production in naturally cycling female rats. Thus, when either heroin or 
heroin-paired cues precede pathogen exposure, typical induction of peripheral pro-inflammatory 
NO biomarkers is attenuated in both sexes. Collectively, our studies provide evidence that heroin 
elicits comparable immunomodulation in both sexes and suggests that the context-heroin 
association formed over the course of an opioid use disorder can extend health consequences past 
drug cessation for both men and women. 
The current study focused on iNOS expression in the spleen and circulating plasma 
degradation products, two indicators of the immune response and peripheral NO production. The 
spleen is key in initiating both the innate and adaptive immune response, and monitors the blood 
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for pathogens and filters out damaged and dead blood cells (Lewis et al., 2019). Although there 
was an observed main effect of sex in heroin-induced suppression of splenic iNOS mRNA, this 
appears to an artifact produced by the main effect of sex seen in the reference gene, L13a. This 
idea is supported by the fact that both splenic iNOS protein and circulating plasma NO 
degradation products are comparably suppressed in both sexes following heroin administration. 
Further, we observe a main effect of drug in both sexes, yet, in males, 1 mg/kg heroin did not 
significantly suppress splenic iNOS mRNA expression relative to saline controls. We have 
previously shown 1 mg/kg is sufficient to suppress LPS-induced iNOS mRNA expression [see 
(Lysle and How, 2000)], and in the current study induction of both splenic iNOS protein and 
plasma nitrate/nitrite concentration were significantly blunted relative to saline controls 
following 1 mg/kg heroin. Taken together, we are confident in our findings that both 1- and 3- 
mg/kg of heroin comparably suppress LPS-induced NO production in both sexes. Given that 
heroin and heroin-CS consistently blunted multiple measures of peripheral LPS-induced NO in 
spleen and blood plasma, we hypothesize that across sex, immune impairment would also be 
observed in other tissues involved in the immune response, such as the liver and lung. This 
possibility is supported by our previous work establishing that in male rats, heroin-induced and - 
conditioned immunomodulation is wide-spread and is found in liver and lung tissue in addition 
to the spleen [see (Lanier et al., 2002; Lysle and How, 2000; Lysle and Ijames, 2002; 
Szczytkowski and Lysle, 2008)]. 
The current investigations focused on NO production in females due to its reliable and 
meaningful suppression by heroin and heroin-CS in males. Previously, we have shown that in 
males the immunomodulatory effects of heroin and heroin-paired CS extend beyond suppression 
of NO to include suppression of peripheral pro-inflammatory cytokines such as interleukin (IL)- 
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1β, IL-6, and TNFα, as well as natural killer cell activity (Saurer et al., 2009; Szczytkowski et 
al., 2011; Szczytkowski and Lysle, 2008). Although the present results demonstrate comparable 
heroin-induced and -conditioned suppression of NO production in males and females, other pro- 
inflammatory immune agents may be differentially regulated based on sex. Females tend to have 
a more robust immune response than males that is in part mediated through direct action of 
female sex hormones on the immune system (Khan and Ansar Ahmed, 2016). For example, 
estradiol has a complex relationship with the immune response and has been shown to exert 
biphasic effects on peripheral pro-inflammatory cytokine production, either enhancing or 
attenuating expression based on estrogen receptor activity. Interestingly, LPS and TLR-signaling 
has been shown to downregulate anti-inflammatory estrogen receptor action, ultimately 
increasing expression of peripheral pro-inflammatory agents (Kovats, 2015). While we did not 
see any evidence of enhanced NO production in females to LPS nor an effect of estrous cycle on 
the actions of heroin or heroin-CS on NO, other immune measures may be modified by female 
sex hormones. The current study was optimized to maximally detect heroin-related changes in 
LPS-induced NO production and is a direct comparison to our previous work using this LPS 
dose and time course to examine heroin-induced and -conditioned NO suppression in male rats 
[e.g. (Lebonville et al., 2020; Lysle and How, 2000; Lysle and Ijames, 2002; Paniccia et al., 
2018)]. Our results are the first to demonstrate comparable heroin-induced suppression of NO 
across multiple measures in both sexes and provide the vital first steps to understanding how 
heroin and heroin-CS alter the immune response in female rats. To examine whether heroin- 
induced and -conditioned NO effects extend to other pro-inflammatory agents or differ based on 
LPS amount and/or frequency, future experiments can alter the time course based on the immune 
24 
 
marker in question and test larger or repeated doses of LPS to explore the interaction of heroin, 
LPS, sex hormones, and cytokine production in female rats. 
The current studies employed naturally cycling female rats and examined estrous stage at 
the point of tissue collection on test day. There appeared to be no effect of estrous cycle, as all 
female samples demonstrate both heroin-induced and -conditioned dampening of the peripheral 
immune response through suppression of peripheral NO production. When samples were 
separated across estrous stage, there was insufficient sample size to adequately assess if 
magnitude of suppression varied across all four phases of the cycle. As such, stages were 
combined and samples characterized as either increasing/higher estradiol (diestrus and proestrus) 
or low estradiol (estrus and metestrus) stages. We observed that females in both the high and low 
estradiol phases exhibit both heroin-induced and -conditioned suppression splenic iNOS 
expression and plasma nitrate/nitrite concentration. Although there are documented sex 
differences in the response to endotoxin challenge (Engler et al., 2016), the current set of 
experiments demonstrate that heroin produces comparable immunomodulation across sex and 
heroin-CS elicits robust suppression of LPS-induced NO production. We have optimized our 
methodology to detect heroin-related changes in NO production, yet, there is the possibility that 
some of our measures (iNOS protein, nitrate/nitrate concentration) are not sensitive enough to 
capture small differences in the magnitude of NO suppression between the sexes. Additionally, 
estrous stages were grouped based on characteristic levels of estradiol across cycle and did not 
account for potential effects of other female sex hormones on NO production, such as 
progesterone. Given these possibilities, future experiments can examine whether female sex 
hormones, including estradiol and progesterone, directly modulate the mechanisms regulating the 
magnitude of heroin-induced and -conditioned suppression of NO in female rats. 
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Results from the current study indicate that there is comparable heroin-induced 
suppression of NO production to endotoxin exposure across sex. This raises the possibility that 
similar neurobiological mechanisms regulate this response in both males and females. 
Previously, we established that heroin’s impact on the peripheral immune response in males is 
mediated by central μ-opioid receptor action [μ-OR; (Nelson et al., 2000)]. As both sexes exhibit 
heroin-induced immunomodulation, it is possible µ-OR signaling is also involved in the 
suppression of LPS-induced NO production in females. Interestingly, our laboratory has shown 
μ-OR signaling exacerbates contact hypersensitivity, an antigen-specific type of cutaneous 
inflammation, in both sexes, with the magnitude of this response being significantly greater in 
female rats (Elliott et al., 2003). Moreover, the increased potentiation of contact hypersensitivity 
in females was contingent on the presence of gonadal sex hormones. As we did not observe sex- 
based differences in heroin-induced immunomodulation, data from our laboratory indicates that 
opioid-immune responses are not uniform and differ based on the response in question and 
biological sex, although they may be mediated through similar central mechanisms. 
The current study is the first to demonstrate context-heroin conditioned suppression of 
typical peripheral NO induction following LPS in female rats. We have extensively characterized 
the neural mechanisms governing heroin-conditioned immunomodulation in male rats and found 
that it is a learned Pavlovian response mediated through hippocampal processes (Szczytkowski et 
al., 2013; Szczytkowski and Lysle, 2007). Using males, we found that dorsal hippocampal (DH) 
signaling is critical for the expression of heroin-conditioned immunomodulation to occur 
(Szczytkowski et al., 2013), and that DH neural immune mechanisms play a causal role in the 
conditioned immune effect [see Chapter 3 and (Paniccia et al., 2018)]. Specifically, astrocytes 
are a critical component during CS exposure for context-heroin conditioned suppression of 
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peripheral NO production to occur (Paniccia et al., 2018). DH astrocytes express estrogen 
receptors, opening the possibility that female sex hormones directly modulate astrocyte activity. 
In fact, estradiol has been shown to mediate astrocyte excitability through Ca2+-induced 
intracellular signaling (Chaban et al., 2004) and influence LPS-induced inflammation in glia 
(Loram et al., 2012). While no sex differences were found in the current study, this could have 
implications for how heroin-conditioned immunomodulation is regulated in females. Future 
experiments can extend this line of work to investigate whether female sex hormones modulate 
astrocyte activity and therefore encoding or recall of the context-heroin association responsible 
for conditioned immunomodulation. 
In addition to the hippocampus, there is considerable overlap in the neural substrates 
governing heroin-conditioned immunomodulation with those involved in other heroin-related 
responses, such as conditioned motivation to take drug (Crombag et al., 2008; Szczytkowski et 
al., 2011). Specifically, dopamine D1 receptor stimulation within the nucleus accumbens shell 
mediates both context-heroin conditioned immunomodulation (Saurer et al., 2008; Saurer et al., 
2009) and heroin seeking behavior (Bossert et al., 2007). The current results demonstrating that 
heroin-induced and -conditioned immunomodulation is present in both sexes are in line with 
literature suggesting males and females respond similarly to heroin and heroin-paired stimuli 
(Lynch et al., 2002; Venniro et al., 2017). Given this, we hypothesize that across sex common 
neurobiological mechanisms govern heroin-induced and -conditioned immunomodulatory and 
motivated responses, albeit there may be crosstalk with steroid sex hormones. For instance, 
dopamine can interact with the female hormone system, mimicking the effects of progesterone 
and stimulating estrogen receptors (Olesen and Auger, 2008; Power et al., 1991). This raises 
questions about whether there is dopamine-hormone interplay regulating heroin-related 
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responses in females, despite the behavioral output to heroin and heroin-CS appearing 
comparable across sex. Moreover, occasional interaction between female sex hormones and 
neurobiological factors may account for some of the existing discrepancies in the literature 
regarding sex differences in heroin-related responses, such as drug taking behavior and reactivity 
to heroin-paired cues. Although we did not observe sex differences in heroin-induced and - 
conditioned immunomodulation, there is ample evidence that female sex hormones interact with 
and may influence the established central mechanisms regulating these immune effects (i.e. 
dopamine activity, astrocyte reactivity, µ-OR signaling). 
In conclusion, the present study is the first to establish that exposure to heroin or heroin- 
CS alter the immune response to a LPS challenge in female rats. When heroin or exposure to a 
heroin-paired context precedes administration of this endotoxin, peripheral NO production, as 
indicated by splenic iNOS expression and plasma nitrate/nitrite concentration, is suppressed in 
females as it is in males. Thus, we have demonstrated that exposure to heroin and heroin-CS 
interferes with normal immune processes and has the potential to alter resistance to infection 
both during and long after drug use, regardless of sex. These experiments are a vital first step to 
fully understanding the negative health consequences associated with heroin use disorders. 
Future lines of research can extend these findings to identify novel treatment strategies that can 
be effective in both sexes to ameliorate the negative impact of heroin and heroin-conditioned 








CHAPTER 3: DORSAL HIPPOCAMPAL IL-1R1 SIGNALING MEDIATES HEROIN- 




Chapter 3 aimed to (i) investigate whether the expression of heroin-conditioned 
immunomodulation is contingent upon DH IL-1R1 signaling, the active IL-1 receptor, and (ii) 
examined CS-induced alterations in expression of both DH IL-1β and IL-1R1, two key 
components of IL-1 signaling. The role of the pro-inflammatory cytokine, interleukin-1β (IL-1β), 
in hippocampal-dependent learning and memory has been well established (Goshen et al., 2007; 
Jones et al., 2015b), with evidence to suggest it’s involvement in the development and 
maintenance of long-term potentiation (Donzis and Tronson, 2014; Yirmiya and Goshen, 2011). 
We have determined IL-1β within the DH is required for the expression of heroin-conditioned 
immunomodulation. siRNA-mediated knock-down of IL-1β within the DH during CS exposure 
blocked the heroin-conditioned suppression of LPS-induced peripheral immune measures 
(Szczytkowski et al., 2013). Interestingly, similar to IL-1β itself, stimulation of IL-1 receptor 
type 1 (IL-1R1) has been implicated in hippocampal-dependent learning and memory. Genetic 
knockouts of hippocampal IL-1R1 show profound deficits in learning tasks and long-term 
potentiation (Ben Menachem-Zidon et al., 2011). Thus, it is likely that IL-1β-dependent memory 
mechanisms occur through IL-1R1 stimulation and subsequent signaling cascades. 
 
 
2Parts of this chapter previously appeared as an article in the journal Brain, Behavior, and Immunity. The original 
citation is as follows: Paniccia, J. E., Lebonville, C. L., Jones, M. E., Parekh, S. V., Fuchs, R. A., & Lysle, D. T. 
(2018). Dorsal hippocampal neural immune signaling regulates heroin-conditioned immunomodulation but not 




Furthermore, we have shown that acquisition of the context-heroin association required for 
conditioned immunomodulation is mediated through DH IL-1R1 (Lebonville et al., 2016). 
However, it is unclear whether DH IL-1R1 signaling is involved in the expression of heroin- 
conditioned immunomodulation. Additionally, heroin CS-induced alterations in the expression 
patterns of DH IL-1β and IL-1R1 remain unknown. To further our understanding, current set of 
experiments examined the effects of DH IL-1R1 antagonism during CS exposure on the 
expression of heroin-conditioned suppression of peripheral NO (Experiment 1) and subsequently 
assessed how DH IL-1β and IL-1R1 mRNA (Experiment 2) and protein (Experiment 3) 
expression change over the course of CS exposure. 
The neural immune system is a vastly complex network involving multiple cell types and 
signaling molecules. These components function in concert to produce persistent adaptations in 
neural communication (Yirmiya and Goshen, 2011). Relevant to our model, astrocyte activity 
has been implicated in both mechanisms of learning and memory (Ben Achour and Pascual, 
2010; Ota et al., 2013) and substance use disorders (Lacagnina et al., 2018; Miguel-Hidalgo, 
2009; Scofield and Kalivas, 2014). Astrocytes can directly alter neuronal function and synaptic 
plasticity through the release of gliotransmitters (Haydon and Carmignoto, 2006) and cytokines 
(Lacagnina et al., 2018; Santello and Volterra, 2012). Interestingly, astroglia have been shown to 
support hippocampal-dependent learning and memory through the expression of IL-1β (Jones et 
al., 2017) and IL-1R1 (Ben Menachem-Zidon et al., 2011). While a mechanistic link between 
astrocyte activity and subsequent IL-1β release has not yet been confirmed, we have recently 
established DH astrocytes are a critical cell population involved in the expression of heroin- 
conditioned immunomodulation. Advancements in chemogenetic tools have made it possible to 
selectively manipulate astrocyte GPCR signaling in vivo to assess the outcome on learned 
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behaviors and drug responses [3, 25, 98-103]. Interestingly, stimulation of endogenous Gi- 
coupled signaling cascades in hippocampal astrocytes decreases reactivity and downregulates the 
IL-1β transcription [5]. To begin to assess the role of astrocytes in our model, we employed 
designer receptors exclusively activated by designer drugs (DREADDs) during CS exposure to 
investigate the consequence of DH astrocyte Gi signaling on the conditioned immune effect. 
Stimulation of astroglial hM4D(Gi) during exposure to the heroin-paired context blocks 
conditioned suppression of peripheral nitric oxide production. As intact astrocyte activity is 
required during CS exposure for the conditioned effect to occur, the current study examined CS- 
induced alterations in astroglial IL-1β and IL-1R1 expression in addition to changes in overall 
DH IL-1 and IL-1R1 mRNA and protein. Collectively, these experiments expand our current 
understanding of how hippocampal IL-1 signaling mediates the context-heroin association 
driving conditioned peripheral immune suppression. 




Adult male Lewis rats (N =101) were purchased from Charles River Laboratories (Kingston, 
NY, USA). Rats were individually housed on a 12-hour reverse light-dark cycle, received ad 
libitum home cage access to food and water, and were handled regularly throughout 
experimentation. All procedures took place during the dark phase of the light cycle and were 
conducted in compliance with regulations set forth by the National Research Council’s Guide for 
the Care and Use of Laboratory Animals and the University of North Carolina at Chapel Hill 




Heroin (diacetylmorphine, National Institute on Drug Abuse Drug Supply Program, Bethesda, MD) 
was dissolved in 0.9% sterile saline. Heroin was stored at 4C until use at room temperature. In all 
experiments, heroin was administered subcutaneously (s.c.) at a dose of 1 mg/kg. This dose was 
selected based on prior research showing that it induces conditioning and alters endotoxin- induced 
indices of NO production (Lysle and Ijames, 2002). Human recombinant interleukin-1 receptor 
antagonist (IL-1RA; Genscript, Piscataway, NJ) was reconstituted in 0.9% sterile saline vehicle to 
a concentration of 2.5 g/L and stored at -20C until use at room temperature. In Experiment 1, 
intra-DH IL-1RA (1.25 µg/0.5-0.6 µL per hemisphere) was infused bilaterally at a rate of 0.25 
µL/min. For Experiment 1, LPS (derived from E. coli, serotype O55:B5, Sigma) was dissolved in 
0.9% sterile saline, pyrogen-free saline to a final concentration of 1 mg/kg and administered s.c.. 
This LPS dose and serotype reliably produces sickness behavior and induces NO production in vivo 
(Lebonville et al., 2020; Paniccia et al., 2018; Paniccia et al., 2021). 
Surgical Procedures 
 
For Experiment 1 animals were implanted with bilateral cannulae for site-directed infusions of 
intra-DH IL-1RA. Animals were fully anesthetized with a 1 mg/kg intraperitoneal injection of 
ketamine hydrochloride (100 mg/mL) mixed with xylazine (100 mg/mL) in a 9:1 (vol:vol) ratio. 
Guide cannulae (26 gauge, Plastics One, Roanoke, VA) were directed bilaterally at the DH [AP - 
3.4 mm, ML  3.1 mm, DV -2.2 mm, relative to bregma, 15° angle laterally, (Paxinos and Watson, 
2006)]. Cannulae were secured to the skull with screws, cyanoacrylate adhesive gel, and dental 
acrylic. Dummy injectors (.008/.2 mm no projection, Plastics One) were inserted into the guide 
cannulae to prevent occlusion. Animals were given one week for post-operative recovery and were 
handled regularly during this time. Sham injections were done 48 h prior to testing to habituate 
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rats to the intracranial infusion procedure. Injectors (33 gauge, Plastics One), without infusion, 
were inserted into the guide cannulae and were left in place for 90 sec. 
Heroin-conditioning procedure 
 
The heroin-conditioning paradigm employed here has been described previously [Chapter 2; 
(Paniccia et al., 2018; Paniccia et al., 2021)]. Briefly, rats received five 1-h pairings of heroin with 
a conditioning chamber (conditioned stimulus, CS). Saline-conditioned (0.9% sterile saline, 1 
mg/kg, s.c.) control animals were included in Experiments 2 and 3, and animals were randomly 
assigned to a drug-conditioning (saline or heroin) treatment. The conditioning chambers 
(BRS/LVE, Laurel, MD; H 26.7 cm × D 24.1 cm × W 30.5 cm) were located in a room separate 
from the vivarium. The chambers contained metal grid flooring and cedar bedding to create an 
environment with different olfactory, tactile, and visual characteristics relative to the home cage. 
The chambers were enclosed within sound- and light-attenuating chambers (H 36.8 cm x D 34.3 
cm x W 50.8 cm) with a house fan to mask background noise. Conditioning sessions took place 
during the dark phase of the light cycle and were separated by 48 h. Following the last conditioning 
session, animals remained undisturbed in their home cage for 6 days, and were randomly assigned 
to a test day treatment. In Experiment 1, a 2 (CS or home cage) x 2 (IL-1RA or vehicle) between- 
subjects design was used. For Experiment 2, a 2 (saline or heroin conditioned) x 2 (CS exposed or 
home cage) between-subjects design was used. Experiment 3 used a 2 (saline or heroin 
conditioned) x 3 (CS exposed time point) between subjects design. 
CS Test 
 
In Experiment 1, animals received bilateral intra-DH infusions of either IL-1RA or vehicle. At the 
end of the infusion, injectors were left in place for 1 min to allow for drug diffusion away from the 
injection site. Thirty minutes after the infusion, animals were re-exposed to the heroin-paired 
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context (CS) for 1 h in the absence of heroin or remained in their home cage. Immediately after 
CS exposure or equivalent home cage stay, animals were injected with LPS and placed into home 
cages until tissue collection, 6 h later. For Experiment 2, tissue was collected immediately 
following 60-minute CS exposure or equivalent home cage stay. In Experiment 3, tissue was 
collected at three time points: home cage (referred to as 0 min), immediately following a 60 min 
CS exposure, and at 120 min following CS onset (animals were exposed to the CS for 60 min and 
placed in home cage for 60 min). 
Tissue collection and histology 
 
Animals were sacrificed via cervical dislocation without anesthesia (Experiments 1 and 2) or 
transcardial perfusion with ice cold 0.1 M Phosphate Buffer (PB, pH= 7.4) followed by 4% 
paraformaldehyde (Experiment 3). As Experiment 1 examined the effect of intra-DH IL-1RA on 
heroin-conditioned immunomodulation, samples of spleen and blood plasma were collected 6 h 
following LPS injection to assess peripheral indices of NO production. Spleen tissue for RNA 
extraction was divided into ~100 mg samples and stored in RNAlater (Ambion, ThermoFisher 
Scientific, Waltham, MA) until time of assay. To verify on-target DH cannula placements in 
Experiment 1, Alcian blue dye was infused via the cannula post-mortem. Afterwards, brain tissue 
was extracted and fixed in 4% paraformaldehyde for 48 h, cryoprotected in 30% sucrose in 0.1 
M phosphate buffer (PB, pH = 7.4), and stored at 4° C. Brain tissue was frozen and sectioned 
into 40 m coronal slices via cryostat (CM3050 S, Leica, Buffalo Grove, IL) and mounted onto 
SuperFrost Plus slides (ThermoFisher Scientific). Tissue sections were analyzed by an 
experimenter blind to treatment group and animals with cannula placement outside of the DH 
were removed from analysis. For Experiment 2, brain tissue was extracted and flash frozen in 2- 
Methylbutane (Millipore-Sigma) and stored at -80 C until sectioning. Brains were mounted with 
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VWR Clear Frozen Section Compound (VWR, Randor, PA, USA) and sectioned via cryostat 
(CM3050 S, Leica) at -20C. Bilateral micropunches of DH tissue were taken (2 mm punches, 8 
per region) and stored in 500 L TriReagent (Molecular Research Center) at -80 C until RNA 
extraction. In Experiment 3, fixed brain tissue was extracted, post-fixed in 4% paraformaldehyde 
for 3 h, cryoprotected in 30% sucrose in 0.1 M PB (pH= 7.4)., and stored at 4 C. Tissue was 
frozen and sliced into 100 m sections via cryostat (CM3050 S, Leica) and stored in ethylene 
glycol at -20C until immunohistochemistry. 
RT-qPCR 
 
RNA Extraction and cDNA Synthesis 
 
In Experiment 1, RNA was extracted from spleen tissue, cDNA was synthesized and diluted, and 
iNOS mRNA was analyzed as described in Chapter 2 (Paniccia et al., 2021). For Experiment 2, 
RNA was extracted from hippocampal tissue to analyze IL-1 and IL-1R1 mRNA expression. 
Hippocampal tissue was homogenized in 500 L TriReagent (Molecular Research Center) using 
a bead homogenizer (Precellys Instruments). Homogenates were briefly centrifuged and 
transferred to Phase Lock Gel tubes (5 Prime, Hilden, Germany). Next, 50 L of BCP (1-Bromo- 
3-Chloropropane; Molecular Research Center) was added, and samples were thoroughly mixed. 
Samples were incubated at room temperature for 15 minutes and centrifuged at 4° C for phase 
separation. The aqueous layer was mixed with isopropanol, incubated at room temperature for 15 
minutes, and centrifuged at 4° C to collect the RNA pellet. RNA pellets were washed three times 
in freshly made 75% ethanol and allowed to air dry to remove residual ethanol. Purified RNA 
was reconstituted in 50 L of warm, PCR-grade water. RNA concentration and purity were 
assessed via spectrophotometer (Epoch™, BioTek Instruments Inc.) using the Take3 Application 
and Gen5 Software for Nucleic Acid Quantification (BioTek Instruments Inc.). 
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Input hippocampal RNA concentration was equalized to 1 μg in PCR-grade water for the 
cDNA reaction. cDNA was synthesized using the Advantage for RT-PCR Kit and Oligo(DT) 
primers (ClonTech, Takara, Mountain View, CA, USA) according to manufacturer’s protocol on 
a Veriti 96 Well Fast Thermal Cycler (Applied Biosystems, ThermoFisher Scientific). cDNA 
was diluted 1:5 in PCR-grade water for qPCR. 
RT-qPCR 
 
Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) was 
performed using the TaqMan™ Fast Advanced Master Mix Kit (Applied Biosystems, 
ThermoFisher Scientific), following the manufacturer’s instructions, to quantify DH IL-1 and 
IL-1R1 mRNA expression. Sample reactions were carried out in triplicate on a 384-well plate, 
with individual reactions containing 1.5 μL of cDNA. Predesigned fluorescein (FAM) assays 
were used to quantify expression of the reference gene GAPDH (Assay ID Rn01775763_g1, 
Life Technologies, AP Biosystems) and target genes IL-1 (Assay ID Rn00580432_m1, Life 
Technologies, AP Biosystems) and IL-1R1 (Assay ID Rn_00565482_m1, Life Technologies, AP 
Biosystems). No template control wells were run concurrently to ensure reaction purity. RT- 
qPCR was run on QuantStudioTM 6 Flex RealTime PCR System (Applied Biosystems, 
ThermoFisher Scientific) using the QuantStudioTM RealTime PCR Software with a PCR Run 
Method as follows: 2 min at 50° C for PCR product contamination degradation; 20 sec hold at 
95°C for polymerase activation; 45 PCR cycles (1 sec at 95° C then 20 sec at 60° C) with data 
collection at the end of each cycle. The comparative delta delta CT (ΔΔCT) method was used for 
data analysis (Schmittgen and Livak, 2008). IL-1 and IL-1R1 CT values were first normalized 
to the reference gene (GAPDH) and then to the mean ∆CT of the saline-conditioned, home cage 
controls. Linearly transformed values were used to display the data graphically. 
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Fluorescent Immunohistochemistry (IHC) 
 
In Experiment 3, fluorescent IHC was performed on free floating 100 m coronal DH slices to 
visualize IL-1, IL-1R1, and the astrocyte marker, GFAP, within three key DH subregions: the 
dentate gyrus, CA3, and CA1. DH tissue sections were incubated in 10% Normal Goat Serum 
(NGS; Vector Laboratories, Burlingame, CA) and 2% Triton-X100 in 0.1 M PB for 60 min at 
room temperature. Next, tissue was incubated for three days in primary antibodies rabbit anti-IL- 
1β (1:500, Ab9722, Abcam, Cambridge, MA) or rabbit anti-IL-1R1 (1:500, Ab106278, Abcam) 
and mouse anti-GFAP (1:1000, Ab-6-1376P, ThermoFisher Scientific) with 10% NGS and 2% 
Triton-X100 in 0.1 M PB at 4° C. Tissue underwent three 5-minute washes in 0.1M PB to 
remove primary antibodies. Tissue was then incubated for three days in secondary antibodies 
goat anti-rabbit AlexaFluor 594 (1:1000, ThermoFisher Scientific) and goat anti-mouse dylight 
405 (1:500, ThermoFisher Scientific), 10% NGS, and 2% Triton-X100 in 0.1 M PB at 4° C. 
Secondary antibodies were removed with three 5-minute washes in 0.1M PB. DH slices were 
mounted onto SuperFrost Plus slides (ThermoFisher Scientific) and coverslipped with 
VectaShield Hardset mounting medium (Vector Laboratories). Specificity of each primary 
antibody was verified in control experiments. 
Image acquisition and Imaris analysis 
 
All images were acquired by an experimenter blind to treatment group using a Zeiss LSM800 
laser-scanning confocal microscope with 405, 488, 561 and 640 diode lasers, Gallium Arsenide 
Phosphid (GaAsP) detectors, and ZEN software suite (ZEN Blue edition, Zeiss, Jena, Germany). 
Six to eight Z-stacks were acquired per DH subregion (dentate gyrus, CA3, and CA1), bilaterally 
per animal using a 20x objective. Acquisition parameters were set to 1024 x 1024 frame size, 16- 
bit resolution, frame average of 4, and 1.25 µm step size. Raw images were deconvolved using 
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AutoQuant software (10 iterations blind deconvolution; Media Cybernetics, Rockville, MD) and 
exported to the Imaris software suite (Bitplane, Zurich, Switzerland). For each Z-stack, an 
experimenter blind to treatment group determined intensity of IL-1, IL-1R1, or GFAP signal 
throughout multiple optical planes and this value was used to threshold positive signal and create 
a surface for the IL-1, IL-1R1, and GFAP data. The surface rendering function enables raw data 
to be masked to the constructed surface to isolate positive signal from background. Volume data 
was extracted from each surface to assess IL-1 and IL-1R1 changes throughout the dentate 
gyrus, CA3, and CA1 subregions. The masked data (Masked IL-1 or Masked IL-1R1 and 
Masked GFAP) were used in colocalization analyses. To assess how IL-1 and IL-1R1 were 
changing within DH astrocytes, GFAP was designated as the region of interest in colocalization 
analyses and data is represented as %GFAP colocalized. Volume and colocalization data was 
averaged across Z-stack per animal. 
Statistical analyses 
 
Data for each experiment was analyzed using analysis of variance (ANOVA) in 
 
SPSS Statistics (IBM, Armonk, NY). In Experiment 1, planned contrasts were made between 
CS-exposed and corresponding home cage control groups, as well as differences between CS- 
exposed groups themselves using a two-tailed independent samples t-test with homogeneity of 
variance determined using Levene’s Test. For analysis of RT-qPCR in both Experiment 1 and 2, 
ΔΔCΤ values were analyzed, although the linearly transformed data were used to display the data 
graphically. Statistically significant outliers were detected using Grubb’s test and removed from 
analysis. Alpha was set at p = 0.05. Fisher’s Least Significant Difference (LSD) post-hoc 






Experiment 1: Intra-DH IL-1RA disrupts heroin-conditioned suppression of NO production 
Experiment 1 examined the role of DH IL-1R1 signaling in the expression of heroin-conditioned 
immunomodulation (for experimental timeline see Fig. 3A). Cannula placements were carefully 
assessed to ensure on target bilateral location in the DH (see Fig. 3B). 
Intra-DH IL-1RA administration prior to CS exposure significantly inhibited heroin- 
conditioned suppression of splenic iNOS mRNA levels (Fig. 3C). A 2x2 ANOVA of ΔΔCT 
revealed no significant differences between groups for splenic Rpl13a mRNA levels (F(3,26) = 
0.38, p = 0.768), validating Rpl13a as an appropriate reference gene. For splenic iNOS mRNA 
levels, a 2x2 ANOVA revealed a significant CS exposure main effect (F(1,26) = 5.31, p = 0.029), 
but no main effect of IL-1RA treatment (F(1,26) = 2.59, p = 0.120). Notably, there was a very 
strong trend for CS exposure x IL-1RA treatment interaction (F(1,26) = 4.06, p = 0.054). Planned 
contrasts revealed that, in the vehicle-treated groups, CS exposure reduced splenic iNOS mRNA 
levels relative to home cage exposure (p < 0.05). Intra-DH IL-1RA administration restored splenic 
iNOS mRNA levels such that CS exposed animals did not differ from IL-1RA-treated home cage 
controls (p = 0.840), and were significantly higher than vehicle-treated CS-exposed animals (p < 
0.05). 
Similar to splenic iNOS mRNA levels, intra-DH IL-1RA administration prior to CS 
exposure significantly inhibited heroin-conditioned suppression of plasma nitrate/nitrite 
concentration (Fig. 3D). A 2x2 ANOVA of plasma nitrate/nitrite concentration revealed a 
significant CS exposure x IL-1RA treatment interaction (F(1,26) = 6.21, p < 0.05). Planned 
contrasts revealed that in vehicle groups, CS exposure reduced plasma nitrate/nitrite concentration 
relative to home cage control exposure (p < 0.05). Intra-DH IL-1RA administration restored 
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plasma nitrate/nitrite concentration such that concentration in IL-1RA treated, CS-exposed groups 
did not differ relative to IL-1RA-treated home cage controls (p = 0.457), and were significantly 
higher than the vehicle-treated CS-exposed group (p < 0.05). 
Experiment 2: Heroin conditioning and CS exposure did not alter DH IL-1β or IL-1R1 gene 
expression 
 
Experiment 2 investigated the consequence of heroin conditioning and CS exposure on IL-1β 
and IL-1R1 mRNA levels within the DH (see Fig. 4A for experimental timeline). Bilateral whole 
DH tissue was microdissected and analyzed (2 mm, 8 punches per rat; Fig. 4B). 
A 2 (drug treatment) x 2 (CS exposure) ANOVA of GAPDH ΔΔCT values revealed no 
main effect of drug conditioning (F(1, 28) = 1.755, p = 0.196), CS exposure (F(1, 28) = 3.399, p 
= 0.076), or interaction between the two (F(1, 28) = 0.052, p = 0.821), validating its use as an 
appropriate reference gene. A 2 x 2 ANOVA of IL-1β ΔΔCT values revealed no significant main 
effects of drug conditioning treatment (F(1, 28) = 0.108, p = 0.744), CS exposure (F(1, 28) = 
0.001, p = 0.979), or drug conditioning x CS exposure interaction (F(1, 28) = 0.458, p = 0.504). 
For IL-1R1, a 2 x 2 ANOVA of ΔΔCT values revealed no main effect of drug conditioning (F(1, 
28) = 0.782, p = 0.384), CS exposure (F(1, 28) = 1.205, p = 0.282), or drug treatment x CS 
exposure interaction (F(1, 28) = 2.567, p = 0.12). 
Experiment 3: Heroin conditioning and CS exposure induces time-dependent increases in IL- 
1β and IL-1R1 expression in CA1 astrocytes 
 
Experiment 3 assessed how heroin conditioning and CS exposure altered IL-1β and IL-1R1 
immunoreactivity within three key DH subregions: the dentate gyrus, CA3, and CA1. 
Subsequently, we investigated the consequence of our manipulations on astrocyte-specific IL-1β 
and IL-1R1 expression (see Fig. 5A, 6A for experimental timeline). The surface rendering 
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function within the Imaris software suite was used to threshold positive signal above background 
(Fig. 5B, 6B). Volume data was extracted from the surface, and the masked data sets used in 




Heroin conditioning and CS exposure did not alter overall IL-1β expression throughout the three 
DH subregions. However, we discovered a time-dependent, region-specific increase in astroglial 
IL-1β colocalization 120 minutes after CS onset within CA1. 
Within the dentate gyrus subregion (Fig. 5C I-III), a 2 (drug conditioned) x 3 (CS 
timepoint) ANOVA of IL-1β volume (I) revealed no main effect of heroin conditioning (F(1, 30) 
= 0.048, p = 0.827), CS exposure time point (F(2, 30) = 2.812, p = 0.076), or interaction between 
heroin conditioning x CS exposure (F(2, 30) = 0.262, p = 0.771). Similarly, a 2 x 3 ANOVA of 
GFAP volume (II) revealed no main effect of heroin conditioning (F(1, 30) = 0.299, p = 0.589), 
CS exposure time point (F(2, 30) = 2.258, p = 0.122), or interaction between the two (F(2, 30) = 
1.169, p = 0.325). A 2 x 3 ANOVA of %GFAP colocalized with IL-1β (III) revealed no main 
effect of heroin conditioning (F(1, 30) = 0.147, p = 0.704), CS exposure (F(2, 30) = 0.918, p = 
0.41), or interaction between heroin conditioning and CS exposure time point (F(2, 30) = 0.151, 
p = 0.860). 
In CA3 (Fig. 5D I-III), a 2 (drug conditioned) x 3 (CS time point) ANOVA of IL-1β 
volume (I) revealed no main effect of heroin conditioning (F(1, 29) = 1.004, p = 0.325), CS 
exposure time point (F(2, 29) = 0.425, p = 0.658), or interaction between the two (F(2, 29) = 
0.419, p = 0.661). For GFAP volume (II), a 2 x 3 ANOVA revealed no significant main effect of 
heroin conditioning (F(1, 30) = 0.385, p = 0.54), CS exposure time point (F(2, 30) = 0.76, p = 
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0.477), or interaction of heroin conditioning x CS exposure time point (F(2, 30) = 0.238, p = 
0.79). A 2 x 3 ANOVA %GFAP colocalized with IL-1β (III) revealed no significant main effect 
of heroin conditioning (F(1,30) = 0.127, p = 0.724), CS exposure time point (F(2,30) = 0.031, p 
= 0.969), or interaction between the two (F(2,30) = 0.198, p = 0.822). 
 
Within the CA1 (Fig. 5E I-III), a 2 (drug conditioned) x 3 (CS time point) ANOVA of 
IL-1β volume (I) revealed no main effect of heroin conditioning (F(1, 30) = 0.09, p = 0.766), CS 
exposure time point (F(2, 30) = 0.634, p = 0.538), or interaction between heroin conditioning 
and CS time point (F(2, 30) = 1.16, p = 0.327). Similarly, a 2 x 3 ANOVA of GFAP volume (II) 
revealed no main effect of heroin conditioning (F(1, 30) = 0.086, p = 0.771), CS exposure time 
point (F(2, 30) = 1.832, p = 0.178), or interaction between the two (F(2, 30) = 0.463, p = 0.634). 
Interestingly, a 2 x 3 ANOVA of %GFAP colocalized with IL-1β (III) revealed a significant 
interaction between heroin conditioning x CS exposure time point (F(2, 30) = 23.501, p = 0.045), 
with no main effect of heroin conditioning (F(1, 30) = 1.636, p = 0.211 or CS exposure time 
point (F(2, 30) = 0.146, p = 0.864). Fisher’s LSD post hoc test revealed that 120 min post CS 
onset, heroin-conditioned animals had increased IL-1β/GFAP colocalization relative to saline- 
conditioned counterparts (p = 0.009; Fig. 5F). 
IL-1R1 Results 
 
Heroin conditioning and CS exposure did not alter overall IL-1β expression throughout the three 
DH subregions. However, we discovered a time-dependent, region-specific increase in astroglial 
IL-1R1 colocalization in heroin-conditioned animals across the 60 min CS exposure. 
Within the dentate gyrus (Fig. 6C I-III), a 2 (drug conditioned) x 3 (CS timepoint) 
ANOVA of IL-1R1 volume (I) revealed no main effect of heroin conditioning (F(1, 27) = 0.082, 
p = 0.777), CS time point (F(2, 27) = 0.079, p = 0.924, or interaction between heroin 
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conditioning and CS time point (F(2, 27) = 0.512, p = 0.605). For GFAP volume (II), a 2 x 3 
ANOVA revealed no main effect of heroin conditioning (F(1,28) = 0.39, p = 0.537), CS time 
point (F(2, 28) = 0.498, p = 0.613), or interaction between the two (F(2, 28) = 0.339, p = 0.715). 
For %GFAP colocalized with IL-1R1 (III), a 2 x 3 ANOVA revealed no main effect of heroin 
conditioning (F(1, 28) = 0.056, p = 0.815), CS time point (F(2, 28) = 0.02, p = 0.981), or 
interaction of heroin conditioning and CS time point (F(2, 28) = 1.357, p = 0.274). 
In CA3 (Fig. 6D I-III), a 2 (drug conditioned) x 3 (CS timepoint) ANOVA of IL-1R1 
volume (I) revealed no main effect of heroin conditioning (F(1, 27) = 1.246, p = 0.274), CS time 
point (F(2, 27) = 0.691, p = 0.51), or interaction between heroin conditioning and CS exposure 
time point (F(2, 27) = 0.202, p = 0.818). For GFAP volume (II), a 2 x 3 ANOVA revealed no 
significant differences in heroin conditioning (F(1, 28) = 3.91, p = 0.058), CS exposure time 
point (F(2, 28) = 1.531, p = 0.234), or interaction between the two (F(2, 28) = 0.116, p = 0.891). 
A 2 x 3 ANOVA of %GFAP colocalized with IL-1R1 (III) revealed no main effect of heroin 
conditioning (F(1, 28) = 0.133, p = 0.718), CS time point (F(2, 28) = 0.156, p = 0.856), or drug 
conditioning x CS time point interaction (F(2, 28) = 0.845, p = 0.44). 
Within the CA1 (Fig. 6E I-III), 2 (drug conditioned) x 3 (CS timepoint) ANOVA of IL- 
1R1 volume (I) revealed no main effect of heroin conditioning (F(1, 28) = 0.001, p = 0.974), CS 
time point (F(2, 28) = 0.171, p = 0.843), or interaction of heroin conditioning x CS time point 
(F(2, 28) = 0.064, p = 0.938). Similarly, for GFAP volume (II), a 2 x 3 ANOVA revealed no 
significant main effect of heroin conditioning (F(1, 28) = 2.15, p = 0.154), CS time point (F(2, 
28) = 0.981, p = 0.387), or interaction between the two (F(2, 28) = 0.331, p = 0.721). A 2 x 3 
ANOVA of %GFAP colocalized with IL-1R1 (III) revealed a significant interaction between 
heroin conditioning and CS time point (F(2, 28) = 3.585, p = 0.041), with no main effect of 
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heroin conditioning (F(1, 28) = 1.347, p = 0.256) or CS exposure time point (F(2, 28) = 0.271, p 
 
= 0.764). Fisher’s LSD post hoc test revealed that immediately following CS exposure, heroin- 
conditioned animals had significantly higher IL-1R1/GFAP colocalization than heroin- 
conditioned, home cage counterparts (p = 0.042; Fig. 6F). 
Discussion 
 
Through associative learning, contextual stimuli can come to elicit heroin-conditioned 
responses such as immunomodulation. The DH plays a critical role in contextual learning and 
memory, and orchestrates the expression of heroin-conditioned immunomodulation (Lebonville 
et al., 2020; Szczytkowski et al., 2013). Additionally, neural immune signaling, in terms of both 
gliotransmission and cytokine signaling, is essential in learning and memory processes (Ben 
Achour and Pascual, 2010; Donzis and Tronson, 2014; Santello and Volterra, 2012; Yirmiya and 
Goshen, 2011) and in some drug-conditioned responses and instrumental behaviors relevant for 
drug addiction (Haydon et al., 2009; Lacagnina et al., 2018; Scofield and Kalivas, 2014). 
Astrocytes, for example, have an established involvement in the IL-1R1 signaling required for 
some forms of learning and memory (Ben Menachem-Zidon et al., 2011), and we have recently 
demonstrated the importance of this cell type in the context-heroin conditioned immune effect 
(Paniccia et al., 2018). Findings in the present study significantly extend these lines of research 
by identifying the DH neuroimmune components responsible for heroin-conditioned 
immunomodulation. Specifically, we show that intact DH IL-1R1-mediated signaling during CS 
exposure is necessary for heroin-conditioned suppression of LPS-induced NO production. This is 
in lined with our earlier work that showed DH IL-1β expression is critical to the heroin- 
conditioned immune effect. Accordingly, the present study examined the consequence of heroin 
conditioning and CS exposure on IL-1β and IL-1R1 expression, two proteins necessary for IL-1 
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signaling to occur. We uncovered time-dependent, region-specific changes in astroglial IL-1β 
and IL-1R1 protein within CA1, demonstrating for the first time a relationship between DH 
astrocytes and IL-1 in our heroin conditioning model. 
The current findings further our understanding of the IL-1 signaling mechanisms 
mediating heroin-conditioned immunomodulation. In a previous study (Szczytkowski et al., 
2013), our laboratory established IL-1β expression is necessary for hippocampal-dependent 
heroin-conditioned immune responses. We demonstrated sustained, inducible knockdown of DH 
IL-1β mRNA expression prior to CS exposure disrupts heroin-conditioned suppression of 
peripheral modulators, including indices of NO production (Szczytkowski et al., 2013). Our 
current results complement these findings by demonstrating IL-1R1-mediated signaling in the 
DH is necessary for the expression of heroin-conditioned immunomodulation. IL-1 signaling is 
complex and very tightly regulated through decoy receptors (i.e. IL-1R2) and endogenous 
receptor antagonists (Boraschi and Tagliabue, 2013). IL-1β is capable of targeting the active 
receptor complex of IL-1R1 and IL-1R accessory protein (IL-1RAP) to induce activation of the 
nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) pathways (Sims and 
Smith, 2010). Within the hippocampus, both astrocytes and microglia are capable of producing 
and responding to IL-1β signaling (Friedman, 2001; Hanisch, 2002), indicating either or both of 
these cell types could facilitate the IL-1 signaling required for heroin-conditioned 
immunomodulation. While the experiments in the present study strongly suggest astroglia are 
involved in DH IL-1 signaling necessary for the heroin-conditioned effect, the additional role of 
DH microglia in this response should be investigated. 
Both pyramidal neurons and astrocytes within the hippocampus can express IL-1R1, and 
IL-1β administration triggers receptor upregulation of this receptor in both cell types (Friedman, 
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2001). Interestingly, IL-1β stimulation of IL-1R1 has distinct signaling consequences for each 
cell population. In hippocampal astrocytes, IL-1β action at IL-1R1 evokes NF-κB signaling 
cascades (Srinivasan et al., 2004) and thus elicits the transcription of pro-inflammatory factors, 
including IL-1β and other cytokines, serving as a potential positive feedback loop for IL-1β 
expression. Conversely, in hippocampal neurons, IL-1β stimulation of IL-1R1 elicits MAPK 
activation and CREB induction (Srinivasan et al., 2004). Since we have established both the 
importance of DH IL-1β expression and IL-1R1 signaling in heroin-conditioned 
immunomodulation, IL-1R1 antagonism in the present study likely impaired heroin-conditioned 
immunomodulation by interfering with the action of IL-1β in both DH pyramidal neurons and 
astrocytes. Consistent with this, stimulation of Gi-coupled DREADDs in both hippocampal 
neurons (Lebonville et al., 2020) and astrocytes (Paniccia et al., 2018) disrupt heroin-conditioned 
suppression of peripheral immune status. Similar to stimulation of neuronal Gi-coupled 
DREADDs, chemogenetic stimulation of astroglial Gi-signaling attenuates cAMP induction 
(Jones et al., 2018b). As converging evidence suggests that activity of NF-κB is modulated by 
cAMP induction (Gerlo et al., 2011), it is possible astroglial Gi-DREADD stimulation would 
attenuate IL-1β production in hippocampal astrocytes, dampening the DH IL-1 signaling 
necessary for conditioned immunomodulation. 
The second set of experiments examined hippocampal IL-1β and IL-1R1 mRNA and 
protein expression following heroin conditioning and CS exposure. Although we did not detect 
alterations in overall DH IL-1β and IL-1R1 mRNA and protein, we uncovered CS-dependent 
changes in astroglial IL-1 expression patterns within the CA1 subregion. For IL-1β, exposure to 
the heroin-paired context increased immunoreactivity in CA1 astrocytes 120 minutes following 
CS onset relative to saline-conditioned controls. Similarly, IL-1R1 immunoreactivity increased 
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in CA1 astrocytes over the course of the 60-minute CS exposure in heroin-conditioned animals. 
Signaling of proinflammatory cytokines, such as IL-1β, induce upregulation of IL-1R1 in 
hippocampal astrocytes (Friedman, 2001; Liu et al., 2019), and in turn, stimulation of astroglial 
IL-1R1 in astrocytes elicits a pro-inflammatory response, cellular activation, and cytokine 
transcription (Liu et al., 2019; Srinivasan et al., 2004). This opens up the possibility that CS 
exposure triggers DH cytokine signaling that increases astroglial IL-1R1, and subsequent IL- 
1R1-mediated signaling resulted in upregulated astroglial IL-1β expression at the 120 minute 
time point. This hypothesis is supported as administration of IL-RA during CS exposure disrupts 
heroin-conditioned suppression of peripheral immune status. Our data indicate astrocytes are 
able to be directly modulated by IL-1 activity and can subsequently increase IL-1β and IL-1R1 
production, thus acting as both a target and source of IL-1 signaling. This feedforward 
mechanism may result in increased overall IL-1 signaling in our model of heroin-conditioned 
immunomodulation. 
The current experiments confirm the importance of the CA1 subregion in heroin- 
conditioned immunomodulation. In a recent study, we employed Gi-coupled DREADDs to 
silence excitatory CA1 and subiculum efferent neurons in both the dorsal and ventral 
hippocampus (VH). Chemogenetic inhibition of DH excitatory outputs during CS exposure 
prevented heroin-conditioned suppression of peripheral nitric oxide production. Conversely, 
stimulation of hM4D(Gi) in outgoing VH pathways did not alter the context-heroin conditioned 
immune effect (Lebonville et al., 2020). These data extended our understanding of how the 
hippocampus differentially regulates the conditioned immune effect and strongly suggest 
involvement of CA1 excitatory pyramidal neurons in this response. Interestingly, the current 
experiments uncovered time-dependent, CS-induced changes in CA1 astrocyte physiology, 
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specifically in IL-1β and IL-1R1 expression patterns. Astrocytes are essential to the neural 
environment and their unique morphology enables them to directly contact, monitor, and regulate 
thousands of synapses with their fine peripheral processes (Agulhon et al., 2008; Arizono et al., 
2020; Chai et al., 2017; Harada et al., 2015), and changes in astrocyte structure and function 
would have ramifications for neuronal communication. Converging evidence suggests IL-1β 
initiates IL-1R-mediated intracellular calcium dynamics in astrocytes to suppress glutamate 
uptake through endocytosis of glutamate transporter 1 (GLT-1) (Yan et al., 2019; Yan et al., 
2014). This would consequentially result in increased extracellular glutamate and changes in 
neuronal excitability. As we have identified the importance of DH excitatory outputs in heroin- 
conditioned immunomodulation, future studies can investigate IL-1-mediated downregulation of 
astroglial GLT-1 and subsequent changes in extracellular glutamate, as well as alterations to 
postsynaptic pyramidal neurons (such as spine density, presence of AMPARs or NMDARs, and 
changes in glutamate receptor expression). Collectively, results from our laboratory open 
exciting research avenues to explore the relationship between cytokine signaling, astrocyte 
reactivity, and neurotransmission regulating context-heroin conditioned immunomodulation. 
In conclusion, the current study is the first to establish DH IL-1R1-mediated signaling 
during heroin-CS exposure drives conditioned suppression of peripheral NO production. 
Moreover, we uncover time-dependent CS-induced changes in astroglial IL-1β and IL-1R1 
expression within the CA1 subreigon, demonstrating for the first time a relationship between 
astrocytes and IL-1 in context-heroin conditioned immunomodulation. The immunomodulatory 
effects of heroin can exacerbate infectious and other disease progression in addicts (Ninković 
and Roy, 2013; Wang et al., 2011). Since immunomodulation can become conditioned to 
environmental stimuli over the course of chronic heroin use, the detrimental health effects of 
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heroin may persist in heroin-associated environments even after cessation of drug use. This 
suggests that interference with specific neural immune substrates that maintain heroin- 
conditioned immunomodulation may be a promising therapeutic target for harm reduction in 








CHAPTER 4: HEROIN CONDITIONING AND CS EXPOSURE INDUCE 





Our recent work establishes that DH astrocytes are involved in the expression of context- 
heroin conditioned immunomodulation (Paniccia et al., 2018). Chapter 4 builds on these data and 
examined heroin-conditioned and CS-induced alterations in DH astrocyte morphology and 
synaptic interactions. Astrocytes are essential in maintaining the neural environment and opioid- 
induced changes in astrocyte morphology and astrocyte-neuron communication may contribute 
to heroin addiction, drug-taking behaviors, and immunomodulation. The unique morphology of 
astrocytes enables them to directly contact, monitor, and regulate thousands of synapses with 
their fine peripheral processes (Agulhon et al., 2008; Arizono et al., 2020; Chai et al., 2017; 
Harada et al., 2015), and changes in astrocyte structure and function consequentially alters 
neurotransmission (Adamsky et al., 2018; Henneberger et al., 2020). As these cells critically 
influence hippocampal learning and memory processes (Adamsky et al., 2018; Kol et al., 2020; 
Savtchouk et al., 2019), alterations in astrocyte physiology may be functionally relevant for the 
context-heroin association to result in conditioned immunomodulation. 
Advancements in chemogenetic tools have made it possible to selectively manipulate 
astrocyte signaling in vivo to assess their role in learned behaviors and drug responses (Adamsky 
et al., 2018; Agulhon et al., 2013; Bull et al., 2014; Jones et al., 2018b; Kol et al., 2020; Nam et 
al., 2019; Scofield et al., 2015; Yang et al., 2015). Our published research employed astroglial 
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DREADDs to examine the role of DH astrocyte signaling during CS exposure on heroin- 
conditioned immunomodulation. We found that stimulation of astroglial hM4D(Gi) during 
exposure to the heroin-paired context blocked conditioned suppression of peripheral nitric oxide 
production. Strikingly, we found that this same manipulation did not alter heroin-conditioned 
place preference, another hippocampal-dependent Pavlovian response (Paniccia et al., 2018). 
Collectively, our data indicate a selective role for DH astrocytes in the expression of Pavlovian 
conditioned responses, and perhaps memory in general. Kol and colleagues recently found that 
stimulation of hM4D(Gi) in CA1 astrocytes has distinct downstream behavioral outcomes for 
remote, but not recent, memory recall. Moreover, Gi-coupled DREADD activation in CA1 
astrocytes directly dampens intra-hippocampal neural communication, as well as inhibits 
outgoing hippocampal projections to the anterior cingulate cortex (Kol et al., 2020). As we have 
established the importance of excitatory DH projections in the expression of heroin-conditioned 
immunomodulation (Lebonville et al., 2020), our previous astrocyte hM4D(Gi) experiments most 
likely altered within-hippocampus neurotransmission and had implications for wider circuit-level 
communication. 
We have established that DH astrocytes have a role in mediating the context-heroin 
association responsible for conditioned immunomodulation, however, virtually nothing is known 
about how heroin conditioning and exposure to heroin-CS alter DH astrocyte physiology, 
including morphology and synaptic connections. Within the nucleus accumbens, there are 
reductions in astroglial synaptic proximity following extinction from heroin self-administration, 
yet after 15 min of cued heroin seeking astrocyte-neuron proximity was restored (Kruyer et al., 
2019). These data suggest that changes in astrocyte structure and synaptic interactions occur 
rapidly and are dependent upon the presence of heroin-paired cues. Hippocampal and striatal 
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astrocytes differ in the number of neuronal contacts per cell, evoked calcium dynamics, 
transcriptomes, and have highly specialized functions within their respective neural circuits 
(Chai et al., 2017). Thus, it may follow that heroin-paired stimuli differentially alter astrocyte 
physiology as a consequence of target brain region examined. 
The current experiments were a comprehensive study into how heroin-conditioned 
contextual stimuli change astrocyte physiology, including cellular morphology and synaptic 
interactions. We employed a cutting-edge neuroscience technique that involves in-depth 
morphological analysis of individual astrocytes and their neuronal interactions. Dr. Kathryn 
Reissner has optimized a method that uses advanced confocal microscopy and software analyses 
to reliably visualize individual astrocytes in rich detail, including their fine peripheral processes, 
to quantify surface area, volume, and colocalization with post synaptic markers throughout a 3- 
dimensional reconstruction (Testen et al., 2019; Testen et al., 2020; Testen et al., 2018). Studies 
to date have used GFAP to examine opioid-induced alterations in hippocampal astrocytes (Song 
and Zhao, 2001), however GFAP constitutes only about 15% of astrocytes total volume, 
providing only a partial or limited image of astrocyte morphology (Benediktsson et al., 2005). 
Dr. Reissner’s advanced method provides rich detail regarding astrocyte morphology, including 
the fine, distal peripheral processes that would be otherwise lost (Scofield et al., 2016b). We 
used an adeno-associated viral construct to selectively express a membrane-tagged GFP in 
hippocampal astrocytes and isolated individual cells to quantify morphology and colocalization 
with PSD-95, a postsynaptic scaffolding protein expressed in glutamatergic neurons. Using the 
reliable GFAP-Lck-GFP construct in combination with IHC, high-resolution confocal 
microscopy, and advanced cellular analyses, the current experiment examined heroin conditioned 
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and CS-induced changes in astrocytes within three key DH subregions: the dentate gyrus, CA3 
and CA1. 




Adult male Lewis rats (N = 38) were purchased from Charles River Laboratories (Kingston, NY, 
USA). Rats were individually housed on a 12-hour reverse light-dark cycle, received ad libitum 
home cage access to food and water, and were handled regularly throughout experimentation. All 
procedures took place during the dark phase of the light cycle and were conducted in compliance 
with regulations set forth by the National Research Council’s Guide for the Care and Use of 
Laboratory Animals and the University of North Carolina at Chapel Hill Institutional Animal 
Care and Use Committee. 
Drug Administration 
 
Heroin (diacetylmorphine, National Institute on Drug Abuse Drug Supply Program, Bethesda, 
MD) was dissolved in 0.9% sterile saline. Heroin was stored at 4C until use at room 
temperature. Heroin was administered subcutaneously (s.c.) at a dose of 1 mg/kg. This dose was 
selected based on prior research showing that it induces conditioning and alters endotoxin- 
induced indices of NO production (Lysle and Ijames, 2002; Paniccia et al., 2021; Szczytkowski 
and Lysle, 2007) 
Surgical Procedures 
 
An astrocyte-specific membrane-tagged GFP construct (AAV5-GFAP-Lck-GFP) was infused 
into the DH in order to completely visualize hippocampal astrocytes. The construct was 
packaged into an adeno-associated virus (AAV) by the University of North Carolina at Chapel 
Hill Vector Core (Chapel Hill, North Carolina). Animals were fully anesthetized with a 1 mg/kg 
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intraperitoneal injection of ketamine hydrochloride (100 mg/mL) mixed with xylazine (100 
mg/mL) in a 9:1 (vol:vol) ratio. Injectors (33 Gauge, Plastics One) were directed bilaterally at 
the DH [AP -3.4 mm, ML  3.1 mm, DV -3.2 mm, relative to bregma, 15° angle laterally 
(Paxinos and Watson, 2006)]. Purified virus was obtained dialysed (350 mM NaCl, 5% D- 
sorbitol in PBS) and were microinjected at a titer of 6.2 x 1012 virus molecules/mL. Virus 
infusions were delivered bilaterally (0.7 L per hemisphere) at a rate of 0.05 μL/min. Injectors 
were left in place for 10 min after virus delivery to allow for diffusion away from the injection 
site. Following stereotaxic surgery, animals remained in home cage for two weeks to allow for 
post-operative recovery and GFP expression. 
Heroin-conditioning procedure 
 
The heroin-conditioning paradigm employed here has been described previously (Paniccia et al., 
2018; Paniccia et al., 2021). Briefly, animals were randomly assigned to a drug-conditioning 
(saline or heroin) treatment. Rats received five 1-h pairings of heroin or saline control (0.9% 
sterile saline, 1 mg/kg, s.c.) with a conditioning chamber (conditioned stimulus, CS). The 
conditioning chambers (BRS/LVE, Laurel, MD; H 26.7 cm × D 24.1 cm × W 30.5 cm) were 
located in a room separate from the vivarium. The chambers contained metal grid flooring and 
cedar bedding to create an environment with different olfactory, tactile, and visual characteristics 
relative to the home cage. The chambers were enclosed within sound- and light-attenuating 
chambers (H 36.8 cm x D 34.3 cm x W 50.8 cm) with a house fan to mask background noise. 
Conditioning sessions took place during the dark phase of the light cycle and were separated by 
48 h. Following the last conditioning session, animals remained undisturbed in their home cage 
for 6 days, and were randomly assigned to a test day treatment: home cage, 60 min CS exposure, 





On test day, saline- and heroin-conditioned animals were either re-exposed to the CS or 
remained in home cage. Tissue was collected at three different time points: (1) animals were 
sacrificed directly from home cage, without exposure to the CS; (2) animals were re-exposed to 
the CS for 60 min followed by immediate tissue collection; (3) animals underwent a 60 min CS 
exposure and then were placed back in their home cage for 60 min before sacrifice (120 min 
following CS onset). 
Tissue collection and histology 
 
Animals were sacrificed via transcardial perfusion with ice cold 0.1 M Phosphate Buffer (PB, 
pH= 7.4) followed by 4% paraformaldehyde. Fixed brain tissue was extracted, post-fixed in 4% 
paraformaldehyde for 3 h, cryoprotected in 30% sucrose in 0.1 M PB (pH= 7.4)., and stored at 4 
C. Tissue was frozen and sliced into 100 m sections via cryostat (CM3050 S, Leica) to ensure 
capture of complete, intact astrocytes. Tissue sections were stored in ethylene glycol at -20C 
until immunohistochemistry. 
Fluorescent Immunohistochemistry (IHC) 
 
Fluorescent IHC was performed on free floating 100 m coronal DH slices to visualize the 
astrocyte marker, GFAP, and postsynaptic marker, PSD-95, within three DH subregions: the 
dentate gyrus, CA3, and CA1. DH tissue sections were incubated in 10% Normal Goat Serum 
(NGS; Vector Laboratories, Burlingame, CA) and 2% Triton-X100 in 0.1 M PB for 60 min at 
room temperature. Next, tissue was incubated for three days in primary antibodies rabbit anti- 
GFAP (1:500, Z0334, Dako, Agilent, Santa Clara, CA) and mouse anti-PSD-95 (1:500, 6G6- 
1C9, Invitrogen, ThermoFisher Scientific) with 10% NGS and 2% Triton-X100 in 0.1 M PB at 
4° C. Tissue underwent three 5-minute washes in 0.1M PB to remove primary antibodies. Tissue 
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was then incubated for three days in Alexa Fluor-conjugated secondary antibodies goat anti- 
mouse Alexa Fluor 594 (1:1000, ThermoFisher Scientific) and goat anti-rabbit Alexa Fluro 647 
(1:1000, ThermoFisher Scientific), 10% NGS, and 2% Triton-X100 in 0.1 M PB at 4° C. 
Secondary antibodies were removed with three 5-minute washes in 0.1M PB. DH slices were 
mounted onto SuperFrost Plus slides (ThermoFisher Scientific) and coverslipped with 
VectaShield Hardset Anti-fade mounting medium with DAPI (H-1500, Vector Laboratories) 
immediately before image acquisition. Specificity of each primary antibody was verified in 
control experiments. 
Image acquisition and Imaris analysis 
 
Image acquisition and analyses were done according to the recent Current Protocols in 
Neuroscience paper by the Reissner group [see (Testen et al., 2020)]. All images were acquired 
by an experimenter blind to treatment group using a Zeiss LSM800 laser-scanning confocal 
microscope with 405, 488, 561 and 640 diode lasers, Gallium Arsenide Phosphid (GaAsP) 
detectors, and ZEN software suite (ZEN Blue edition, Zeiss, Jena, Germany). Three to eight Z- 
stacks were acquired per DH subregion (dentate gyrus, CA3, and CA1), bilaterally per animal 
using a 63x oil-immersed objective. Acquisition parameters were set to 1024 x 1024 frame size, 
16-bit resolution, frame average of 4, and 0.8 µm step size. Raw images were deconvolved using 
AutoQuant software (10 iterations blind deconvolution; Media Cybernetics, Rockville, MD) and 
exported to the Imaris software suite (Bitplane, Zurich, Switzerland). The surface rendering 
function of Imaris was used to isolate individual astrocytes within each 3-dimensional 
reconstructed Z-stack. Raw data from the GFP channel was masked to the experimenter- 
determined surface to isolate GFP signal from background and neighboring cells (Fig. 7A). 
Surface area and volume data was extracted from each surface to quantify morphological 
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changes in DH astrocytes within the dentate gyrus, CA3, and CA1 subregions. Astrocytic 
branches have been shown to contribute more towards cellular surface area than volume (Hama 
et al., 2004), as such the surface area/volume ratio was also analyzed as a proxy of cellular 
complexity. The Masked-GFP channel was designated a region of interest (ROI) and used in 
colocalization analysis. Signal intensity of PSD-95 was determined by an experimenter blind to 
treatment group by taking repeated intensity measures across multiple optical planes of the Z- 
stack, and the average value of these intensity measures was used as the threshold for PSD-95 
positive signal in colocalization analysis (Fig.7B). Colocalization data is represented as %ROI. 
Overall changes in voxles of PSD-95 within each Z-stack was checked by automatically 
counting the number of positive signal above the predetermined PSD-95 intensity threshold 
within an assigned 25 µm x 25 µm x 25 µm cube for each sample. 
Statistical analysis 
 
Surface area, volume, surface area/volume ratio, and colocalization data (%ROI) of saline- and 
heroin-conditioned groups was analyzed using Nested Analysis of Variance (ANOVA) in the 
SAS program (SAS Institute, Cary, NC) for each CS exposure time point. Results are reported as 
mean values and standard error. Alpha was set at p = 0.05. 
Results 
 
The current study examined how a history of heroin conditioning and CS exposure affected the 
structural properties of DH astrocytes and astrocyte-neuron interactions within three subregions 
(dentate gyrus, CA3, and CA1) using an astrocyte-specific membrane-tagged GFP construct, 
high magnification confocal microscopy, and Imaris analyses of 3-D cellular reconstructions (see 
Fig. 8-13, panel A for timeline and tissue collection points). Surfaces were created using the 
GFP channel to extract morphological metrics and isolate the GFP signal for colocalization 
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analysis. In the dentate gyrus, morphology data from two different tissue sets were pooled 
together for final analysis of cell surface area and volume in this region. Final group sizes at each 
time point used in analyses for saline- and heroin-conditioned animals in each region were as 
follows: Home cage (no CS exposure) contained n = 4 saline-conditioned animals (41 cells, 20 
used in colocalization analysis) and n = 6 heroin-conditioned animals (63 cells, 32 used in 
colocalization analysis) for the dentate gyrus, n = 4 saline-conditioned animals (21 cells, all used 
in colocalization analysis) and n = 6 heroin-conditioned animals (31 cells, all used in 
colocalization analysis) in CA3, n = 4 saline conditioned (17 cells, all used in colocalization 
analysis) and n = 5 heroin-conditioned animals (25 cells, all used in colocalization analysis) in 
CA1; CS exposure (60 minute time point) contained n = 5 saline-conditioned animals (47 cells, 
21 used in colocalization analysis) and n = 8 heroin-conditioned animals (82 cells, 38 used in 
colocalization analysis) in the dentate gyrus, n = 4 saline-conditioned animals (14 cells, all used 
in colocalization analysis) and n = 8 heroin-conditioned animals (46 cells, all used in 
colocalization analysis) in CA3, n = 5 saline-conditioned animals (19 cells, 18 used in 
colocalization analysis) and n = 8 heroin-conditioned animals (39 cells, 38 used in colocalization 
analysis) in CA1; CS Exposure + home cage stay (120 minute time point) contained n = 5 
saline-conditioned animals (48 cells, 22 used in colocalization analysis) and n = 7 heroin- 
conditioned animals (67 cells, 33 used in colocalization analysis) in the dentate gyrus, n = 5 
saline-conditioned animals (26 cells, all used in colocalization analysis) and n = 7 heroin- 
conditioned animals (35 cells, all used in colocalization analysis) in CA3, and n = 5 saline- 
conditioned animals (25 cells, all used in colocalization analysis) and n = 7 heroin-conditioned 
animals (36 cells, all used in colocalization analysis) in CA1. All image acquisition took place 
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within the target DH subregion, and any subregion that was not transduced with the AAV5- 
GFAP-Lck-GFP construct was excluded from analysis. 
A history of heroin conditioning did not change DH astrocyte morphology, but increased 
PSD-95 positive puncta within the dentate gyrus 
 
Animals that were conditioned with either saline or heroin, but not exposed to the CS displayed 
no differences in DH astrocyte morphology (Fig. 8B-D). In the dentate gyrus (Fig. 8B), there 
was no difference in surface area [saline 30,770 ± 1,872.56 µm2, heroin 30,770 ± 1,872 µm2, 
F(1, 8) = 0.05, p = 0.828], volume [saline 14,909 ± 1,301.98 µm3, heroin 13988 ± 1050.33 µm3, 
F(1, 8) = 0.30, p = 0.597], or ratio of the two [data not shown; saline 2.244 ± 0.093 µm-1, heroin 
2.405 ± 0.075 µm-1, F(1, 8) = 1.79, p = 0.217] between saline- and heroin-conditioned rats. 
 
Similarly within the CA3 (Fig. 8C), there were no differences in astrocyte surface area [saline 
48,271 ± 2854.45 µm2, heroin 56,091 ± 2,349 µm2, F(1, 8) = 4.47, p = 0.067], volume [saline 
31,956 ± 2,946.98 µm3, heroin 34,200 ± 2,425.53 µm3, F(1, 8) = 0.35, p = 0.573], or surface 
 
area/volume ratio [data not shown; saline 1.629 ± 0.110 µm-1, heroin 1.808 ± 0.091 µm-1, F(1, 8) 
 
= 1.56, p = 0.246] between saline- and heroin-conditioned animals. Within the CA1 (Fig. 8D), 
no significant differences were detected in cell surface area [saline 71,391 ± 4,485.49 µm2, 
heroin 65,830 ± 3698.83 µm2, F(1, 7) = 0.91, p = 0.371], volume [saline 45,103 ± 3667.58 µm3, 
heroin 47,977 ± 3,034 µm3, F(1, 7) = 0.37, p = 0.564], or ratio of the two [data not shown; saline 
1.713 ± 0.139 µm-1, heroin 1.484 ± 0.114 µm-1, F(1, 7) = 1.63, p = 0.243] between saline- and 
heroin-conditioned animals. 
Although we detected no alterations in astrocyte structure across the DH, a history of 
heroin-conditioning increased PSD-95 expression within the dentate gyrus (Fig. 9B). An 
increase in colocalization of PSD-95 with dentate gyrus astrocytes (isolated GFP channel) 
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accompanied this overall increase in PSD-95-positive puncta. The Nested ANOVA revealed 
increased PSD-95 positive voxels [saline 2,909 ± 586.24, heroin 4,778.50 ± 463.46, F(1, 8) = 
6.23, p = 0.037] in heroin-conditioned animals relative to saline-conditioned counterparts. This 
increase in overall PSD-95 expression accounted for the increased colocalization of PSD-95 with 
dentate gyrus astrocytes [saline 1.733 ± 0.735%, heroin 4.418 ± 0.581%, F(1, 8) = 8.22, p = 
0.021] in heroin-conditioned animals compared to saline-conditioned animals. In contrast, within 
CA3 (Fig. 9C) there were no significant differences detected in PSD-95 colocalization [saline 
2.722 ± 0.3945 %, heroin 2.045 ± 0.325%, F(1, 8) = 1.76, p = 0.222] or PSD-95 positive puncta 
[saline 3,776.90 ± 340.64, heroin 3,444.90 ± 280.37, F(1, 8) = 0.57, p = 0.473] between saline- 
and heroin-conditioned animals. Similarly, in CA1 (Fig. 9D) there were no differences in PSD- 
95 colocalization [saline 4.606 ± 0.725%, heroin 2.749 ± 0.598, F(1, 7) = 3.91, p = 0.089] or 
PSD-95 positive puncta [saline 3,710.29 ± 366.87, heroin 3072.96 ± 302.53, F(1, 7) = 1.80, p = 
0.222] between saline- and heroin-conditioned animals. 
Exposure to heroin-conditioned stimuli alters astrocyte morphology and PSD-95 
colocalization 
 
Exposure to the heroin-paired context significantly altered the structural properties of DH 
astrocytes (Fig. 10B-D), as well as astrocyte-neuron interactions (Figure 11B-D). Within the 
dentate gyrus (Fig.10B), there were no changes in astrocyte surface area [saline 32,942 ± 
2,101.44 µm2, heroin 33,869 ± 1,590 µm2, F(1, 11) = 0.12, p = 0.732], volume [saline 14,254 ± 
758.07 µm3, heroin 14,693 ± 758.07 µm3, F(1, 11) = 0.12, p = 0.733], or surface area/volume 
ratio [data not shown; saline 2.379 ± 0.084 µm-1, heroin 2.400 ± 0.064 µm-1, F(1, 11) = 0.04, p = 
0.846] detected following CS exposure between saline- and heroin-conditioned animals. 
However within CA3 (Fig.10C), the Nested ANOVA revealed CS exposure did not change 
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astrocyte surface area [saline 44,9026 ± 3,903.98 µm2, heroin 50,248 ± 2,153.74 µm2, F(1, 10) = 
1.44, p = 0.259] or surface area/volume ratio [data not shown; saline 2.026 ± 0.142 µm-1, heroin 
1.739 ± 0.078 µm-1, F(1, 10) = 3.14, p = 0.107], but increased overall cell volume [saline 23,607 
± 2,915.8 µm3, heroin 31,084 ± 1,608.58 µm3, F(1, 10) = 5.04, p = 0.049] in heroin-conditioned 
animals relative to saline-conditioned counterparts. Within CA1 (Fig.10D), CS exposure 
significantly decreased astrocyte surface area [saline 75,891 ± 3,921.04 µm2, heroin 64,108 ± 
2,736.82 µm2, F(1, 11) = 6.07, p = 0.031] in heroin-conditioned animals relative to saline- 
conditioned counterparts. There was no change in CA1 astrocyte volume [saline 47,941 ± 
3,574.66 µm3, heroin 44,700 ± 2,495.05 µm3, F(1, 11) = 0.55, p = 0.473] or surface area/volume 
ratio [data not shown; saline 1.686 ± 0.132 µm-1, heroin 1.596 ± 0.092 µm-1, F(1, 11) = 0.31, p = 
0.586] detected between CS exposed saline- or heroin-conditioned animals. 
Within the dentate gyrus (Fig. 11B), the Nested ANOVA did not detect differences in 
either PSD-95 colocalization [saline 4.114 ± 0.786%, heroin 4.234 ± 0.584, F(1, 11) = 0.02, p = 
0.904] or PSD-95 puncta [saline 4,735.76 ± 452.55, heroin 4,501.24 ± 336.42, F(1, 11) = 0.17, p 
 
= 0.686] in CS exposed saline- or heroin-conditioned animals. Within CA3 (Fig. 11C), CS 
exposure significantly decreased astrocyte colocalization with PSD-95 [saline 4.501 ± 0.777%, 
heroin 2.440 ± 0.429%, F(1, 10) = 5.39, p = 0.043] in heroin-conditioned animals relative to 
saline-conditioned counterparts. Importantly, there was no change in number of PSD-95 puncta 
[saline 4,222.21 ± 559, heroin 3,535.04 ± 308.82, F(1, 10) = 1.16, p = 0.308] between CS 
exposed saline- or heroin-conditioned animals. In CA1 (Fig. 11D), there was no change in 
astrocyte colocalization with PSD-95 [saline 3.163 ± 0.380%, heroin 2.548 ± 0.261%, F(1, 11) = 
1.78, p = 0.209] in CS exposed saline- or heroin-conditioned animals despite an overall decrease 
in PSD-95 puncta [saline 4,358.78 ± 346.88, heroin 3,396.21, F(1, 11) = 5.23, p = 0.043]. 
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Exposure to the heroin-paired context changes astrocyte complexity and synaptic interactions 
120 minutes following CS onset 
 
CS exposure followed by a 60 min home cage stay did not alter DH astrocyte surface area and 
volume independently (Fig 12B-D), but increased the ratio between cell surface area/volume 
within CA3 and CA1 (Table 1) in heroin-conditioned animals relative to saline-conditioned rats. 
In the dentate gyrus (12B), the Nested ANOVA revealed no significant differences in astrocyte 
surface area [saline 31,708 ± 2,281.38 µm2, heroin 36,154 ± 1,930.99 µm2, F(1, 10) = 2.21, p = 
0.168], volume [saline 16,361 ± 1,510.51 µm3, heroin 16,615 ± 1278.52 µm3, F(1, 10) = 0.02, p 
 
= 0.901], or ratio of the two [saline 2.238 ± 0.102 µm-1, heroin 2.359 ± 0.086 µm-1, F(1, 10) = 
0.83, p = 0.3837] at the 120 min time point between saline- and heroin-conditioned animals. 
Within CA3 (12C), although there were no significant differences detected in astrocyte surface 
area [saline 49,241 ± 3,271.39 µm2, heroin 54,852 ± 2,819.58 µm2, F(1, 10) = 1.69, p = 0.223] or 
volume [saline 33,029 ± 2,354.10 µm3, heroin 29,804 ± 2,028.98 µm3, F(1, 10) = 1.08, p = 
0.324] between saline- and heroin-conditioned animals 120 min after CS onset, heroin- 
conditioned animals had an increased surface are/volume ratio [saline 1.618 ± 0.120 µm-1, heroin 
1.984 ± 0.103 µm-1, F(1, 10) = 5.37, p = 0.043] relative to saline-conditioned counterparts 
indicating increased astrocyte complexity. Similarly in CA1 (12D), there were no significant 
differences in astrocyte surface area [saline 70,798 ± 4,432.41 µm2, heroin 78,957 ± 3,693.67 
µm2, F(1, 10) = 2.00, p = 0.188] or volume [saline 54,189 ± 3,521.82 µm3, heroin 44,652 ± 
2,934.85 µm3, F(1, 10) = 4.33, p = 0.064] between saline- and heroin-conditioned animals at the 
120 min time point, however, heroin-conditioned animals had an increased surface area/volume 
ratio [saline 1.4387 ± 0.127 µm-1, heroin 1.921 ± 0.106 µm-1, F(1, 10) = 8.45, p = 0.016] relative 
to the saline-conditioned group. 
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In addition to these increases in the surface area/volume ratio, exposure to the heroin- 
paired context increased astrocyte-neuron interactions within CA1 120 following CS onset. 
Within the dentate gyrus (Fig. 13B), the Nested ANOVA revealed no significant differences in 
colocalization of PSD-95 with astrocytes [saline 3.975 ± 0.909%, heroin 4.865 ± 0.742%, F(1, 
10) = 0.58, p = 0.465] or number of PSD-95 positive puncta [saline 4,082.27 ± 483.86, heroin 
4,727.18 ± 395.07, F(1, 10) = 1.07, p = 0.326] between saline- and heroin-conditioned animals at 
the 120 minute time point. Similarly within CA3 (Fig. 13C), there were no significant 
differences in colocalization of PSD-95 signal [saline 2.896 ± 0.481%, heroin 2.526 ± 0.415%, 
F(1, 10) = 0.34, p = 0.573] or number of PSD-95 puncta [saline 2.896 ± 0.481, heroin 2.526 ± 
0.415, F(1, 10) = 0.34, p = 0.573] between saline- and heroin-conditioned animals following a 60 
min CS exposure and 60 min home cage stay. In CA1 (Fig. 13D), the Nested ANOVA revealed a 
significant increase in PSD-95 colocalization with astrocytes [saline 1.799 ± 0.414%, heroin 
3.182 ± 0.345%, F(1, 10) = 6.59, p = 0.028] in heroin-conditioned animals relative to the saline- 
conditioned group following a 60 min CS exposure and subsequent home cage stay. Importantly, 
there was no significant difference in number of PSD-95 positive puncta [saline 3001.88 ± 
337.88, heroin 3892.25 ± 281.57, F(1, 10) = 4.11, p = 0.070] between saline- and heroin- 
conditioned animals at the 120 min time point. 
Discussion 
 
The present experiment was a comprehensive study of how heroin-conditioned 
contextual stimuli affect astrocyte physiology, including cellular morphology and synaptic 
interactions. We established that a history of heroin conditioning and exposure to previously 
heroin-paired cues directly alters PSD-95-positive post synaptic puncta, astrocyte structure, and 
astrocyte-neuron interactions in all three DH subregions examined. The dentate gyrus, CA3, and 
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CA1 subregions comprise the intrinsic circuitry of the hippocampus, facilitating information 
flow within region, as well as receiving incoming and transmitting outgoing connections 
(Knierim, 2015). A history of context-heroin conditioning increased the number of PSD-95- 
positive puncta within the dentate gyrus, one of the primary hippocampal input regions, and this 
was accompanied by increased astrocyte colocalization with PSD-95. Furthermore, exposure to 
heroin-conditioned contextual stimuli immediately increased astrocyte volume but decreased 
colocalization with post synaptic markers within CA3. At this same time point, exposure to 
heroin-CS decreased CA1 astrocyte surface area, however, these cells retained their synaptic 
interactions despite a decrease in number of PSD-95-positive puncta. Interestingly, a 60-minute 
heroin-CS exposure followed by 60-minute home cage stay did not independently change 
astrocyte surface area and volume, but increased the surface area/volume ratio of cells in both 
CA3 and CA1, indicating increased cellular complexity. In CA1, this was accompanied by 
increased astrocyte colocalization with PSD-95, suggesting an increase in astrocyte-neuron 
interactions 120 minutes following CS onset. These CS-induced changes in astrocyte structure 
and astrocyte-neuron interactions appear to be heterogeneous across the hippocampus and occur 
in a time-dependent manner. As our laboratory has reproducibly demonstrated the importance of 
hippocampal neuronal communication in the expression of heroin-conditioned 
immunomodulation, CS-induced changes in astrocyte physiology could have functional 
implications for within-hippocampal neurotransmission as well as wider circuit-level 
connectivity governing contextually conditioned responses. 
The functional integrity of the dorsal dentate gyrus is essential to the expression of 
context-reward conditioned responses (Hernández-Rabaza et al., 2008). As one of the major 
hippocampal inputs regions, the dentate gyrus receives cortical information from the entorhinal 
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cortex via the perforant pathway (Knierim, 2015). In particular, glutamatergic projections from 
the entorhinal cortex to the dorsal dentate gyrus are responsible for context-induced 
reinstatement of heroin seeking, with exposure to the heroin-paired context upregulating the 
GluN2B subunit of NMDARs within the dentate gyrus (Ge et al., 2017). Stimulation of these 
GluN2B-containing NMDARs appears to be essential for enhanced synaptic plasticity (Ge et al., 
2007) and is functionally related to the expression of context-induced reinstatement of heroin 
seeking behavior (Ge et al., 2017). Consistently, the current results demonstrate a history of 
heroin conditioning increases PSD-95 expression in the dorsal dentate gyrus, suggesting 
increased post synaptic glutamatergic terminals in this subregion in heroin-conditioned animals 
relative to saline controls. Long-term potentiation (LTP) is regarded as the molecular basis of 
learning and memory and is dependent upon stimulation of NMDAR (Lüscher and Malenka, 
2012). The increased presence of glutamatergic post synaptic terminals could indicate the 
occurrence of LTP in heroin-conditioned animals. Future lines of research can expand on the 
current results and assess changes in NMDAR expression, specifically GluN2B-containing 
receptors, in the dorsal dentate gyrus following the heroin-conditioning procedure. Further, 
involvement of the glutamatergic connections between the entorhinal cortex and dorsal dentate 
gyrus should be assessed in the expression of heroin-conditioned peripheral immunomodulation. 
The current investigations indicates that exposure to heroin-conditioned contextual 
stimuli induces alterations to hippocampal astrocytes in a subregion-dependent manner. Within 
CA3, we observed increased cell volume and decrease neuronal contacts as a result of a 60 min 
heroin-CS exposure. Projections from CA3 are essential for intra-hippocampus communication, 
with CA3-CA1 projections, CA3-dentate gyrus feedback connections, and within-CA3 collateral 
connections all regulating learning processes, memory formation, and recall (Knierim, 2015). 
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Importantly, astrocytes are functionally regulate the synaptic transmission between CA3-CA1 for 
learning and memory mechanisms (Kol et al., 2020). Stimulation of μ-ORs, a main site of heroin 
action, has been shown to induce LTP at CA3 synapses (Derrick et al., 1992). Moreover, 
hippocampal astrocytes themselves express μ-ORs with stimulation increasing astroglial 
glutamate release (Nam et al., 2021), suggesting that astrocytes play a pivotal role in μ-OR- 
induced hippocampal synaptic plasticity. Recent work demonstrates decreased presence of 
perisynaptic astroglial processes following LTP induction at CA3 to CA1 synapses (Henneberger 
et al., 2020). Interestingly, increased astrocyte size has been shown to accompany increased 
neuronal excitability and glutamate presence in some pathologies (Murphy et al., 2017). This 
opens the possibility that the observed heroin-CS induced increase in astrocyte volume but 
decrease in colocalization with PSD-95 in the current study is a result of CA3 astrocyte swelling 
and activity-dependent retraction of astroglial processes from synapses. 
Exposure to the heroin-conditioned context also affected CA1 astrocyte physiology and 
number of PSD-95-positive puncta. We detected decreased CA1 astrocyte surface area but 
retention of neuronal interactions, despite an overall decrease in number of PSD-95 puncta. 
Results from this timepoint indicate heroin-CS-induced alterations in astrocyte physiology occur 
heterogeneously throughout different hippocampal subregions. Astrocytes tile the brain and have 
distinct cellular domains within neuronal circuitry. Moreover, recent work has shown the cellular 
and molecular diversity of astrocytes both between and within brain regions of interest (Chai et 
al., 2017; Khakh and Deneen, 2019). The current study demonstrates that exposure to heroin- 
conditioned contextual stimuli has distinct outcomes for astrocyte structure and neuronal 
interactions depending on target subregion examined. Although exposure to heroin-CS induced 
decreases in CA1 astrocyte surface area, these cells maintained astrocyte-neuron connections 
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despite an overall decrease in post synaptic puncta. This finding may be functionally relevant to 
the expression of context-heroin conditioned immunomodulation as we previously established 
that dorsal CA1 glutamatergic projections during heroin-CS exposure drive conditioned 
suppression of peripheral NO production (Lebonville et al., 2020). As opposed to the decrease in 
astrocyte-neuron interactions in CA3, it appears imperative for contact between CA1 astrocytes 
and excitatory neurons to be intact during CS exposure for the expression of heroin-conditioned 
immunomodulation. These results open exciting research avenues to investigate the interaction 
of CA1 astrocyte activity on outgoing glutamatergic projections, neurotransmitter release, and 
neuronal morphology. 
The current results suggest that heroin-conditioned contextual stimuli elicit increased 
astrocyte complexity and neuronal contacts long after exposure has ended. Although we 
observed no independent changes in cell surface area or volume, we uncovered increased surface 
area/volume ratio within both the CA3 and CA1 subregions in animals that underwent heroin-CS 
exposure and subsequent home cage stay. Astroglial branching contributes more towards cell 
surface area than volume (Hama et al., 2004), suggesting that changes in surface area/volume 
ratio are indicative of astrocyte complexity with possible implications for astrocyte-neuron 
interactions. This is supported by the observed increase in CA1 astrocyte colocalization with 
PSD-95 120 min following heroin-CS onset, despite the number of PSD-95-positive puncta 
remaining the same. These findings suggest that immediately following exposure to the heroin- 
paired context CA1 astrocytes maintain their neuronal contacts, and increase synaptic presence 
over the course of the next 60 minutes. CA1 astrocytes are crucial in facilitating hippocampal 
synaptic plasticity and extra-hippocampal neurotransmission involved in memory acquisition 
(Adamsky et al., 2018) and remote memory recall (Kol et al., 2020). These cells induce long- 
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lasting synaptic adaptations and enhance learning processes beyond what is seen with neuronal 
activity alone (Adamsky et al., 2018). Future lines of research should investigate the functional 
relevance of increased astrocyte complexity in CA3 and CA1 cells, and test whether this is 
related to increased CA3-CA1 communication following exposure to the heroin-paired context. 
Moreover, we have shown that stimulation of astroglial Gi-coupled DREADDs disrupts the 
expression of heroin-conditioned immunomodulation. Follow-up experiments should explore the 
outcome of this manipulation on astrocyte structure and neuronal contacts, as well as on CA1 
synaptic plasticity and outgoing neuronal activity. 
In summary, the present study is the first to investigate how a history of heroin 
conditioning and exposure to heroin-paired contextual stimuli affect DH astrocyte structure as 
well as their neuronal interactions. We uncovered a plethora of changes throughout the 
hippocampal subregions examined and found that heroin-CS induced changes in astrocyte 
physiology are not uniform and occur on different time scales following stimulus exposure. A 
history of heroin conditioning itself increases the number of excitatory post synaptic terminals 
within the dentate gyrus, but does not affect the morphological properties of DH astrocytes. In 
contrast, exposure to heroin-conditioned contextual stimuli increases astrocyte size and decreases 
neuronal interactions in CA3, yet decreases CA1 astrocyte structure but cells maintain synaptic 
interactions despite a decrease in excitatory post synaptic puncta. Further, heroin-CS cause 
longer-lasting changes in astrocyte physiology, increasing DH astrocyte complexity (in both 
CA3, CA1) 120 minutes after onset of exposure. This was accompanied by increased CA1 
astrocyte colocalization with PSD-95, suggesting an increase in astroglial presence at the 
synapse. As DH astrocytes modulate the expression of heroin-conditioned peripheral 
immunomodulation, the functional implications of these CS-induced changes in astrocyte 
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structure and neuronal contacts requires further scientific examination. This experiment was a 
necessary first step to better understand the consequence of heroin conditioning and heroin-CS 
exposure on the hippocampal mechanisms governing context-heroin conditioned responses. 
Results identify neural targets that can be used to disrupt the context-heroin association driving 








CHAPTER 5: GENERAL DISCUSSION 
 
Results from the current set of experiments indicate three key findings. First, heroin- 
induced and -conditioned suppression of peripheral NO production is present in both sexes. We 
assessed how heroin administration and exposure to heroin-conditioned contextual stimuli 
modulated endotoxin-induced iNOS expression and nitrate/nitrite concentration, two of the most 
sensitive and reliable measures of immune status in vivo. When either heroin or heroin-CS 
preceded the LPS challenge both biomarkers of NO production were markedly decreased relative 
to saline controls across sex. These data add to the growing body of literature exploring sex- 
based effects in heroin-related responses and behaviors. We demonstrate that similar to males, 
the female immune response is susceptible to modulation by both heroin and exposure to heroin- 
paired cues, suggesting these effects persist long after drug cessation. Our work in males 
established that heroin-conditioned immunomodulation is indeed a contextually conditioned 
response (Szczytkowski and Lysle, 2007), and is mediated by dorsal hippocampal processes 
(Lebonville et al., 2020; Szczytkowski et al., 2013). As both males and females express heroin- 
conditioned immunomodulation, we hypothesize the DH orchestrates the conditioned effect 
across sex. 
Within the DH, we found that the pro-inflammatory cytokine, IL-1β, is key in the 
expression of heroin-conditioned suppression of LPS-induced NO production. siRNA 
knockdown of IL-1β prior and during exposure to the heroin-paired context abolished 
conditioned suppression of peripheral immune measures (Szczytkowski et al., 2013). IL-1 
signaling is complex and very tightly regulated through decoy receptors (i.e. IL-1R2) and 
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endogenous receptor antagonists (Boraschi and Tagliabue, 2013). Along with IL-1α, IL-1β is 
capable of targeting the active receptor complex of IL-1R1 and IL-1R accessory protein (IL- 
1RAP) to stimulate a pro-inflammatory response on multiple cell types (Sims and Smith, 2010). 
This leads to the second finding of the current research program: stimulation of IL-1R1, the 
active IL-1 receptor, is necessary during exposure to the heroin-conditioned context for the 
expression of conditioned immunomodulation. Using a pharmacological strategy, blockade of 
DH IL-1 signaling during CS exposure abolished heroin-conditioned suppression of LPS- 
induced peripheral NO production (Paniccia et al., 2018). While IL-1 signaling can act on both 
neurons and glia (Friedman, 2001; Liu et al., 2019; Srinivasan et al., 2004), our previous work 
established the role of hippocampal astrocytes in modulating the heroin-conditioned immune 
effect. Stimulation of astroglial Gi-coupled designer receptors exclusively activated by designer 
drugs (DREADDs) during exposure to the heroin-CS disrupted the expression of conditioned 
immunomodulation (Paniccia et al., 2018). In the current study, we examined whether heroin- 
conditioned contextual stimuli altered IL-1β and IL-1R1 expression within DH astrocytes in 
addition to more global DH changes in cytokine and receptor expression. Although we did not 
detect CS-induced alterations in either DH IL-1β or IL-1R1 expression, we found that these 
proteins changes within astrocytes in a time-dependent, region-specific manner. Astroglial IL- 
1R1 expression increased over the course of a 60-minute exposure to the heroin-conditioned 
context within the CA1, specifically. Furthermore, IL-1β expression was elevated in CA1 
astrocytes 120 minutes following CS onset (60-minute CS exposure + 60-minute home cage stay 
group). We hypothesize that the upregulation of IL-1R1 in CA1 astrocytes during CS exposure is 
functionally related to the increased astroglial IL-1β one hour following removal from the 
context. Intact DH IL-1R1-mediated signaling is required during CS exposure for the expression 
71 
 
of conditioned immunomodulation (Paniccia et al., 2018), and stimulation of IL-1R1 on 
astrocytes initiates pro-inflammatory signaling cascades that result in increased cytokine 
transcription and cytokine receptor expression (Friedman, 2001; Srinivasan et al., 2004). CS- 
induced upregulation of astroglial IL-1β and IL-1R1 could have consequences for cell 
morphology, gliotransmission, neurotransmitter uptake, synaptic contacts, and downstream 
behavioral results. 
The third finding from the current research program was that classical conditioning with 
heroin and exposure to heroin-conditioned contextual stimuli changes DH glutamatergic 
postsynaptic puncta, astrocyte structural properties, and interaction of astrocytes with these 
glutamatergic synapses. We found these changes to be heterogenous throughout the DH and 
occur on different time scales following CS exposure. We uncovered that a history of classical 
heroin conditioning increased PSD-95-positive puncta in the dentate gyrus, one of the main input 
areas of the DH (Knierim, 2015), and this was accompanied by an increase in astrocyte-neuron 
interactions. Next, we found that exposure to the heroin-conditioned context affects astrocytes in 
two hippocampal subregions, CA3 and CA1. A 60-minute heroin-CS exposure increased CA3 
astrocyte volume but decreased the number of synaptic interactions these cells had. Likewise, we 
observed CA1 astrocytes had decreased surface area, however, these cells maintained their 
neuronal contacts despite an overall decrease in number of PSD-positive puncta. Finally, 
following a 60-minute CS exposure and equivalent home cage stay, we found no changes in 
astrocyte surface area or volume independently, yet saw increases in the surface area/volume 
ratio in CA3 and CA1 in heroin-conditioned animals. Astrocyte branching and peripheral 
processes contribute more towards the cell surface area than volume (Hama et al., 2004), 
suggesting that our results show increased astrocyte complexity 120 minutes following heroin- 
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CS onset. Moreover, CA1 astrocytes increased astrocyte-neuron connections at the 120-minute 
time point. 
Taken together, results from the current study provide much needed insight into the 
health detriments that stem from context-heroin associations. Our findings demonstrate heroin 
and heroin-conditioned contextual stimuli negatively modulate the immune response in both 
sexes. The expression of context-heroin conditioned peripheral immunomodulation is 
orchestrated by DH neuroimmune mechanisms, with CS exposure affecting multiple aspects of 
this system such as cytokine protein and receptor expression, astrocyte morphology, and 
astrocyte-neuron interactions. The changes caused by CS exposure on DH neuroimmune 
components are likely related, with these interactions necessary for the expression of heroin- 
conditioned suppression of peripheral immune status. 
Our published data and the current result suggest that DH astrocytes (1) regulate the 
context-heroin association responsible for peripheral immune impairment (Paniccia et al., 2018); 
(2) upregulate expression of IL-1R1 and IL-1β following heroin-CS exposure; and (3) 
consequently alter structure and synaptic contacts as a result of CS exposure. We successfully 
implemented astroglial Gi-coupled DREADDs to manipulate DH astrocyte signaling in vivo and 
examine the consequence on behavior. We have shown that stimulation of DH astroglial Gi- 
signaling during exposure to heroin-paired stimuli disrupts conditioned immunomodulation. 
Interestingly, stimulation of endogenous Gi-coupled signaling cascades in hippocampal 
astrocytes decreases reactivity and downregulates the IL-1β transcription (Zhou et al., 2020). 
This is supported by a small pilot study from our laboratory indicating that stimulation of 
hM4D(Gi) in DH astrocytes downregulates LPS-induced IL-1β expression in DREADD-positive 
cells (Paniccia, unpublished observations). These findings open the possibility that stimulating 
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astroglial Gi-DREADDs in our previous experiment disrupted heroin-conditioned 
immunomodulation by preventing CS-induced increases in astroglial IL-1R1 and IL-1β. It is 
important to consider that stimulation of hM4D(Gi) activates astrocytes and elicits intra-cellular 
calcium dynamics similar to hM3D(Gq) (Durkee et al., 2019; Nagai et al., 2019). However, 
stimulation of hM4D(Gi) in hippocampal astrocytes results in smaller and shorter calcium 
fluctuations (Chai et al., 2017; Kol et al., 2020), and endogenous Gi-coupled signaling produces 
weak calcium responses (Chai et al., 2017). In contrast, stimulation of both hM3D(Gq) and 
endogenous Gq-coupled signaling evokes robust calcium signals in hippocampal astrocytes (Chai 
et al., 2017), similar to the calcium dynamics initiated by IL-1R1 stimulation (Pita et al., 1999). 
Use of chemogenetic tools in astrocytes is becoming more frequent, however, investigating the 
distinct cellular outcomes of either the Gi- or Gq-coupled pathway is complex and still in its 
infancy. Importantly, the consequence of astroglial GPCR signaling on cytokine production is a 
novel use for DREADD technology and an unexplored outcome of stimulation. Future 
experiments should employ both types of astroglial DREADDs, hM4D(Gi) and hM3D(Gq), in 
the expression of heroin-conditioned immunomodulation to examine potential bi-directional 
effects on astroglial IL-1 dynamics. 
The current study revealed CA1 as the primary DH subregion involved in IL-1-related 
changes following exposure to heroin-conditioned contextual stimuli. Moreover, at the time 
points we observed astrocyte-specific increases in IL-1R1 and IL-1β, there were changes to 
astrocyte structure and synaptic interactions. Most notably, one hour after animals were taken out 
of the heroin-conditioned context, IL-1β was significantly elevated in CA1 astrocytes and these 
cells displayed increased cellular complexity and glutamatergic synaptic interactions. Cytokines 
have an established role in learning and memory mechanisms (Yirmiya and Goshen, 2011), with 
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astroglial IL-1R1-mediated signaling underlying hippocampal synaptic plasticity (Ben 
Menachem-Zidon et al., 2011) and IL-1β upregulated during long-term potentiation of synaptic 
transmission (Schneider et al., 1998). Stimulation of astroglial IL-1R1 may alter excitatory 
neuronal transmission through endocytosis of GLT-1 (Yan et al., 2019; Yan et al., 2014) and 
decrease astrocyte glutamate uptake (Hyvärinen et al., 2019). As a result, IL-1 signaling would 
increase the presence of extracellular glutamate at the synapse with potential effects on 
neurotransmission. Interestingly, recent work indicates astrocyte-derived IL-33, a member of the 
IL-1 family of cytokines (Fields et al., 2019), regulates CA1 synaptic plasticity through 
excitatory synapse formation and recruitment of PSD-95 (Wang et al., 2021). Collectively these 
findings indicate that astrocytes can act as both a target and source of cytokine signaling and 
consequentially modulate excitatory synaptic transmission in CA1. As we recently established 
the role of dorsal CA1 glutamatergic projection in mediating heroin-conditioned 
immunomodulation, the current results open exciting research avenues to examine the 
consequence of astrocyte-derived IL-1 signaling on CA1 dendritic spine growth, neuronal 
excitability, and activity of downstream CA1 projection targets. 
Additionally, cytokines have been shown to influence astrocyte morphology. Prolonged 
treatment with IL-1β and TNFα initiated pro-inflammatory response and caused astrocytes to 
become more spherical, losing their filamentous structure (Hyvärinen et al., 2019). This was 
examined using GFAP and vimentin, proteins found in the astrocyte cytoskeleton and 
intermediate filaments. It is currently unknown how (1) physiological levels of IL-1β modulate 
astrocyte morphology and (2) cytokine signaling affects peripheral astrocyte processes. 
Collectively results from the current study indicate that astroglial complexity and IL-1β 
expression are increased in CA1 at the same time point. However, these two findings may have 
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occurred independently of each other. CA3 astrocyte complexity similarly increased 60 minutes 
following the end of heroin-CS exposure, however, there were no changes in CA3 astroglial IL- 
1β expression at this time point. Future studies can directly test the outcome of IL-1β 
administration and/or IL-1R1 antagonism on astrocyte structure and synaptic interactions using 
the Lck-GFP construct and uncover the relationship between IL-1 signaling and astrocyte 
physiology in heroin-conditioned immunomodulation. 
Results from the current research program demonstrate that heroin-CS elicit changes in 
astrocyte physiology that are heterogenous throughout the DH. Our data adds to a growing body 
of literature that suggests drug-related changes in astrocyte structure and synaptic proximity are 
not uniform and differ based on of drug of abuse, presence of an abstinence period, exposure to 
drug-related cues, and brain region examined. For instance, the Reissner laboratory reliably 
demonstrates a retracted morphological phenotype and decreased synaptic colocalization within 
the nucleus accumbens following prolonged cocaine self-administration and extinction (Scofield 
et al., 2016a; Testen et al., 2018). Interestingly, there are reductions in astrocyte-neuron 
interactions within the nucleus accumbens following heroin extinction as well, with astrocyte- 
neuron proximity restored following a 15-minute cued heroin seeking test (Kruyer et al., 2019). 
Hippocampal and striatal astrocytes differ in the number of neuronal contacts per cell, evoked 
calcium dynamics, transcriptomes, and have highly specialized functions within their respective 
neural circuits (Chai et al., 2017). Taken with the current results, these findings indicate that 
heroin-induced changes in astrocyte morphology and synaptic interactions are transient, occur in 
a time-dependent manner following heroin-paired cues, and may be altered differentially as a 
consequence target brain region examined. 
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In order to examine the consequence of heroin-CS on peripheral immune status we 
employ LPS as bacterial challenge immediately following the exposure session. LPS is an 
established model of bacterial infection that reliably induces a pro-inflammatory response in the 
peripheral nervous system. We are reliably able to detect how exposure to heroin-conditioned 
contextual stimuli modulates the production of NO in peripheral tissue and plasma. In the current 
study, experiments investigating how a history of heroin conditioning altered DH neuroimmune 
components were carried out in the absence of LPS challenge. LPS, as on test day, would likely 
alter DH IL-1β and IL-1R1 expression patterns, astrocyte structure and function, and astrocyte- 
neuron interactions following administration. For instance, LPS disrupted LTP in perforant 
pathway neurons of the dentate gyrus in an IL-1β dependent manner (Kelly et al., 2003), 
indicating an endotoxin challenge on test day would influence memory recall through cytokine 
activity. Additionally, it is possible that the neuroimmune alterations induced by exposure to the 
heroin-conditioned context are exacerbated by LPS challenge. Manipulations occur prior to 
exposure to the heroin-conditioned context on test day, and the neurobiological mechanisms that 
occur during heroin-CS exposure lay the ground work for the expression of heroin-conditioned 
suppression of LPS-induced NO production. Thus, the heroin-CS-induced increase in astroglial 
IL-1R1 over the course of exposure provides an increased number of glial targets for LPS- 
induced cytokine signaling upon administration. Future experiments should investigate how CS- 
induced changes in DH IL-1β, IL-1R1, astrocyte structure, and astrocyte-neuron contacts 
compare following LPS challenge. 
In summary, the current research was highly significant and provided critical insight into 
the neurobiological mechanisms governing context-heroin conditioned peripheral 
immunomodulation. Both males and females express heroin-conditioned suppression of LPS- 
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induced peripheral NO production, and we hypothesize that similar neural mechanisms modulate 
this conditioned effect across sex. The functional integrity of the dorsal hippocampus, as well as 
the outgoing projections, is crucial for the expression of context-heroin conditioned 
immunomodulation. Within the DH, we established the importance of neuroimmune signaling in 
the expression of the conditioned immune effect. These interdisciplinary studies furthered our 
understanding of how hippocampal neuroimmune mechanisms, such as cytokine expression and 
signaling and astrocyte physiology, are influenced by CS exposure and modulate the context- 
heroin association responsible for conditioned immune impairment. Results identify novel 
therapeutic targets to disrupt the context-heroin association and prevent heroin-paired 
environmental stimuli from impairing immune function. 
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FIGURES AND FIGURE CAPTIONS 
Chapter 2 “Female rats express heroin-induced and -conditioned…” Figure 1 
 
Figure 1. Heroin administration suppresses LPS-induced indices of peripheral NO production. 
Experimental timeline (A). For females, both heroin doses (1- and 3-mg/kg) significantly 
suppressed iNOS mRNA levels relative to saline-treated counterparts; while only 3 mg/kg heroin 
suppressed LPS-induced iNOS mRNA in males as compared to saline counterparts (B). In both 
sexes, a 1- or 3-mg/kg dose of heroin blunts LPS-induced splenic iNOS protein (C) and plasma 
nitrate/nitrite concentration (D) relative to saline-treated controls. E-G depicts the data of female 
rats separated by estrous stages with low or high/increasing estradiol in saline- and heroin-treated 
groups. Regardless of estrous distinction, heroin significantly suppressed LPS-induced splenic 
iNOS mRNA (E) and protein (F), as well as plasma nitrate/nitrite concentration (G) relative to 
saline-treated controls. *, statistically significant main effect of heroin. ^, statistically significant 
difference from male counterpart. n.s., no significant differences between saline treated and 1- 
mg/kg heroin males. Error bars indicate SEM. 
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Chapter 2 “Female rats express heroin-induced and -conditioned…” Figure 2 
 
 
Figure 2. Females express heroin-conditioned suppression of LPS-induced indices of NO 
production. Experimental timeline (A). Following context-heroin conditioning with 1 mg/kg 
heroin, exposure to heroin-conditioned stimuli (CS) blunts LPS-induced splenic iNOS mRNA (B) 
and protein (C), as well as plasma nitrate/nitrite concentration (D) relative to heroin-conditioned 
home cage controls and both saline-conditioned groups. E-G depicts data from heroin-conditioned 
female rats separated into low or increasing/high estradiol groups. Regardless of estrous 
distinction, CS exposure significantly suppressed LPS-induced splenic iNOS mRNA (E) and 
protein (F) as well as plasma nitrate/nitrite concentration (G) relative to home cage controls. *, 
statistically significant difference from heroin-conditioned control. Error bars indicate SEM. 
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Chapter 3 “Dorsal hippocampal IL-1R1 signaling mediates heroin-conditioned…” Figure 3 
 
 
Figure 3. Intra-DH IL-1RA disrupts heroin-conditioned suppression of peripheral indices of NO 
production. The experimental timeline (A) and cannula placements (B) are depicted for 
Experiment 1. Black dots indicate the ventral most point of the injector. Coordinates represent 
distance from bregma based on the rat brain atlas of Paxinos and Watson (2006). Intra-DH 
administration of IL-1RA significantly disrupted heroin-conditioned LPS-induced splenic iNOS 
mRNA expression (C) and plasma nitrate/nitrite concentration (D). Group sizes were n = 7-8 for 
the final analysis of splenic iNOS mRNA expression and plasma nitrate/nitrate concentration. * 




Chapter 3 “Dorsal hippocampal IL-1R1 signaling mediates heroin-conditioned…” Figure 4 
 
 
Figure 4. Heroin conditioning and CS exposure do not change overall DH IL-1β and IL-1R1 
mRNA levels. The experimental timeline (A) and representative 2 mm micropunch placements 
(B) are shown for Experiment 2. Coordinates represent distance from bregma based on the rat 
brain atlas of Paxinos and Watson (2006). Heroin conditioning and CS exposure did not 
significantly change overall DH IL-1β (C) or IL-1R1 (D) mRNA levels from saline-conditioned 
counterparts. Group sizes were n = 8 for the final analyses. 
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Chapter 3 “Dorsal hippocampal IL-1R1 signaling mediates heroin-conditioned…” Figure 5 
 
Figure 5. Heroin-CS induce IL-1β expression in CA1 astrocytes. Experimental timeline shown in 
 
A. The surface building feature of Bitplane Imaris was used to isolate positive signal (B). 
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Volume data was extracted from the surface for IL-1β and GFAP, with masked data sets used in 
colocalization analysis. There were no changes within the dentate gyrus (C), CA3 (D), or CA1 
(E) in IL-1β (I) or GFAP (II) volume. Heroin-CS exposure increased IL-1β colocalization in 
GFAP-positive CA1 astrocytes 120 minutes following CS onset (E. III), with no change in 
%GFAP colocalized observed in the dentate gyrus (C. III) or CA3 (D. III). F depicts 
representative CA1 images from saline- and heroin-conditioned rats at the 120 min time point 
depicting increased colocalization between IL-1β (Alexa Fluor-594) and GFAP (dylight-405). * 
represents statistically significantly difference from saline-conditioned conditioned counterpart 
(p < 0.05). Group size was n = 5-8. 
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Chapter 3 “Dorsal hippocampal IL-1R1 signaling mediates heroin-conditioned…” Figure 6 
 
Figure 6. Heroin-CS induce IL-1R1 expression in CA1 astrocytes across exposure. Experimental 
timeline shown in A. The surface building feature of Bitplane Imaris was used to isolate positive 
signal (B). Volume data was extracted from the surface for IL-1R1 and GFAP, with asked data 
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sets used in colocalization analysis. There were no changes within the dentate gyrus (C), CA3 
(D), or CA1 (E) in IL-1R1 (I) or GFAP (II) volume. Heroin-CS increased IL-1R1 colocalization 
in GFAP-positive CA1 astrocytes across a 60 min exposure (E. III), with no change in %GFAP 
colocalized observed in the dentate gyrus (C. III) or CA3 (D. III). F shows representative CA1 
images from heroin-conditioned, CS exposed animals in which IL-1R1 (orange) and GFAP 
(pink) colocalization increased from the home cage group. * represents statistically significantly 
difference from heroin-conditioned, home cage counterpart (p < 0.05). Group size was n = 4-8. 
Imaris was used to change the color of the IL-1R1 and GFAP signal for image display. 
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Chapter 4 “Heroin conditioning and CS exposure induce changes…” Figure 7 
 
Figure 7. GFAP-Lck-GFP can be used to isolate hippocampal astrocytes and examine astrocyte- 
neuron interactions. A representative 63x oil-immersion confocal Z-stack is shown of a GFAP- 
positive (Alexa-647) DH astrocyte expressing Lck-GFP. A depicts isolation of the astrocyte using 
the surface building function of Bitplane Imaris. We are able to extract surface area and volume 
data from the generated 3-dimensional surface. In B, the isolated astrocyte (Masked-GFP channel) 
can then be used to analyze colocalization with PSD95 (Alexa-594) and quantify synaptic 
interactions with neurons. 
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Figure 8. A history of heroin conditioning does not alter DH astrocyte morphology. 
Experimental timeline shown in A. The surface building feature of Bitplane Imaris was used to 
create a surface surrounding the Lck-GFP signal to isolate individual cells and morphometric 
data was extracted from the surface (B-D panel I). No changes were detected within the dentate 
gyrus (B), CA3 (C), or CA1 (D) in astrocyte surface area (I) or volume (II) between saline- and 
heroin-conditioned animals. Mean and SEM for each dataset is shown. 
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Chapter 4 “Heroin conditioning and CS exposure induce changes…” Figure 9 
 
Figure 9. A history of heroin conditioning increases PSD-95 expression in the dentate gyrus. 
Experimental timeline shown in A. In the dentate gyrus (B), heroin conditioning significantly 
increased astrocyte colocalization with PSD-95 (I) which is attributed to the increased number of 
PSD-95 positive puncta (II) in this subregion. In contrast, there were no differences observed in 
either CA3 (C) or CA1 (D) PSD-95 colocalization (I) or overall expression (II). Panel III 
depicts representative 63x oil-immersion Z-stacks of the isolated GFP, PSD-95 (Alexa Fluor- 
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594), and generated colocalization channel. * represents statistically significant difference from 
saline-conditioned counterpart (p < 0.05). 
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Figure 10. Exposure to heroin-CS induces changes in astrocyte structure. Experimental timeline 
shown in A. The surface building feature of Bitplane Imaris was used to create a surface 
surrounding the Lck-GFP signal to isolate individual cells and obtain morphometric data (B-D 
panel I). There were no significant changes in astrocyte surface area or volume detected 
following CS exposure within the dentate gyrus (B I-II). In CA3 (C), CS exposure did not 
change surface area (I), but increased astrocyte volume (II) in heroin-conditioned animals 
relative to saline-conditioned counterparts. Within CA1 (D), CS exposure decreased astrocyte 
surface area (I), but did not change cell volume (II), in heroin-conditioned animals relative to 
saline-conditioned counterparts. * represents statistically significant difference from saline- 





Chapter 4 “Heroin conditioning and CS exposure induce changes…” Figure 11 
 
Figure 11. CS exposure induces changes in DH astrocyte-neuron interactions. Experimental 
timeline shown in A. There were no differences observed within the dentate gyrus (B) in either 
astrocyte colocalization with PSD-95 (I) or number of PSD-95 positive puncta (II). Within the 
CA3 (C), CS exposure significantly decreased astrocyte colocalization with PSD-95 (I) in 
heroin-conditioned animals relative to saline-conditioned counterparts. Importantly, CS exposure 
did not alter the overall number of PSD-95 puncta in CA3 (II). In CA1 (D), CS exposure did not 
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alter astrocyte colocalization with PSD-95 (I) despite decreasing overall PSD-95 puncta (II) in 
heroin-conditioned animals as compared to saline-conditioned rats. Panel III depicts 
representative 63x oil-immersion Z-stacks of the isolated GFP, PSD-95 (Alexa Fluor-594), and 
generated colocalization channel. * represents statistically significant difference from saline- 
conditioned counterpart (p < 0.05). 
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Figure 12. CS Exposure and subsequent home cage stay does not independently change 
astrocyte surface area or volume. Experimental timeline shown in A. The surface building 
feature of Bitplane Imaris was used to create a surface surrounding the Lck-GFP signal to isolate 
individual cells and morphometric data was extracted from the surface (B-D panel I). No 
changes were detected within the dentate gyrus (B), CA3 (C), or CA1 (D) in astrocyte surface 
area (I) or volume (II) between saline- and heroin-conditioned animals. Mean and SEM for each 
dataset is shown. 
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Chapter 4 “Heroin conditioning and CS exposure induce changes…” Figure 13 
 
Figure 13. Exposure to heroin-conditioned contextual stimuli induces increased CA1 astrocyte- 
neuron interactions 120 following CS onset. Experimental timeline shown in A. There were no 
differences observed within the dentate gyrus (B) or CA3 (C) in either astrocyte colocalization 
with PSD-95 (I) or number of PSD-95 positive puncta (II). Within the CA1 (D), CS exposure 
significantly increased astrocyte colocalization with PSD-95 (I) in heroin-conditioned animals 
relative to saline-conditioned counterparts at the 120 min time point. Importantly, CS exposure 
and subsequent home cage stay did not alter the overall number of PSD-95 puncta in CA1 (II). 
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Panel III depicts representative 63x oil-immersion Z-stacks of the isolated GFP, PSD-95 (Alexa 
Fluor-594), and generated colocalization channel. * represents statistically significant difference 
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